<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2018-01-31" version="248">
<accession>P00533</accession>
<accession>O00688</accession>
<accession>O00732</accession>
<accession>P06268</accession>
<accession>Q14225</accession>
<accession>Q68GS5</accession>
<accession>Q92795</accession>
<accession>Q9BZS2</accession>
<accession>Q9GZX1</accession>
<accession>Q9H2C9</accession>
<accession>Q9H3C9</accession>
<accession>Q9UMD7</accession>
<accession>Q9UMD8</accession>
<accession>Q9UMG5</accession>
<name>EGFR_HUMAN</name>
<protein>
<recommendedName>
<fullName>Epidermal growth factor receptor</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Proto-oncogene c-ErbB-1</fullName>
</alternativeName>
<alternativeName>
<fullName>Receptor tyrosine-protein kinase erbB-1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">EGFR</name>
<name type="synonym">ERBB</name>
<name type="synonym">ERBB1</name>
<name type="synonym">HER1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1984" name="Nature" volume="309" first="418" last="425">
<title>Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells.</title>
<authorList>
<person name="Ullrich A."/>
<person name="Coussens L."/>
<person name="Hayflick J.S."/>
<person name="Dull T.J."/>
<person name="Gray A."/>
<person name="Tam A.W."/>
<person name="Lee J."/>
<person name="Yarden Y."/>
<person name="Libermann T.A."/>
<person name="Schlessinger J."/>
<person name="Downward J."/>
<person name="Mayes E.L.V."/>
<person name="Whittle N."/>
<person name="Waterfield M.D."/>
<person name="Seeburg P.H."/>
</authorList>
<dbReference type="PubMed" id="6328312"/>
<dbReference type="DOI" id="10.1038/309418a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Mol. Reprod. Dev." volume="41" first="149" last="156">
<title>Possible role of variant RNA transcripts in the regulation of epidermal growth factor receptor expression in human placenta.</title>
<authorList>
<person name="Ilekis J.V."/>
<person name="Stark B.C."/>
<person name="Scoccia B."/>
</authorList>
<dbReference type="PubMed" id="7654368"/>
<dbReference type="DOI" id="10.1002/mrd.1080410205"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="4050" last="4056">
<title>A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Maihle N.J."/>
</authorList>
<dbReference type="PubMed" id="8918811"/>
<dbReference type="DOI" id="10.1093/nar/24.20.4050"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Gynecol. Oncol." volume="65" first="36" last="41">
<title>Expression of a truncated epidermal growth factor receptor-like protein (TEGFR) in ovarian cancer.</title>
<authorList>
<person name="Ilekis J.V."/>
<person name="Gariti J."/>
<person name="Niederberger C."/>
<person name="Scoccia B."/>
</authorList>
<dbReference type="PubMed" id="9103388"/>
<dbReference type="DOI" id="10.1006/gyno.1996.4526"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Genomics" volume="71" first="1" last="20">
<title>Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Threadgill D.W."/>
<person name="Eley G.D."/>
<person name="Strunk K.E."/>
<person name="Danielsen A.J."/>
<person name="Schehl Sinclair C."/>
<person name="Pearsall R.S."/>
<person name="Green P.J."/>
<person name="Yee D."/>
<person name="Lampland A.L."/>
<person name="Balasubramaniam S."/>
<person name="Crossley T.D."/>
<person name="Magnuson T.R."/>
<person name="James C.D."/>
<person name="Maihle N.J."/>
</authorList>
<dbReference type="PubMed" id="11161793"/>
<dbReference type="DOI" id="10.1006/geno.2000.6341"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 3 AND 4)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of the cDNA for a short EGF receptor from human placenta.</title>
<authorList>
<person name="Xu L."/>
<person name="Hong A."/>
<person name="He X."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="7">
<citation type="submission" date="2004-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS GLN-98; ARG-266; LYS-521; ILE-674; GLY-962 AND PRO-988</scope>
</reference>
<reference key="8">
<citation type="submission" date="1999-02" db="EMBL/GenBank/DDBJ databases">
<title>Human and mouse alternative EGFR transcripts encoding only the extracellular domain of the receptor.</title>
<authorList>
<person name="Reiter J.L."/>
<person name="Threadgill D.W."/>
<person name="Danielsen A.J."/>
<person name="Schehl C.M."/>
<person name="Lampland A.L."/>
<person name="Balasubramaniam S."/>
<person name="Crossley T.O."/>
<person name="Magnuson T.R."/>
<person name="Maihle N.J."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 575-687</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1984" name="Science" volume="224" first="843" last="848">
<title>Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells.</title>
<authorList>
<person name="Lin C.R."/>
<person name="Chen W.S."/>
<person name="Kruiger W."/>
<person name="Stolarsky L.S."/>
<person name="Weber W."/>
<person name="Evans R.M."/>
<person name="Verma I.M."/>
<person name="Gill G.N."/>
<person name="Rosenfeld M.G."/>
</authorList>
<dbReference type="PubMed" id="6326261"/>
<dbReference type="DOI" id="10.1126/science.6326261"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 713-924</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1984" name="Nature" volume="309" first="806" last="810">
<title>Human epidermal growth factor receptor cDNA is homologous to a variety of RNAs overproduced in A431 carcinoma cells.</title>
<authorList>
<person name="Xu Y.H."/>
<person name="Ishii S."/>
<person name="Clark A.J.L."/>
<person name="Sullivan M."/>
<person name="Wilson R.K."/>
<person name="Ma D.P."/>
<person name="Roe B.A."/>
<person name="Merlino G.T."/>
<person name="Pastan I."/>
</authorList>
<dbReference type="PubMed" id="6330563"/>
<dbReference type="DOI" id="10.1038/309806a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 150-962</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1984" name="Biochem. Biophys. Res. Commun." volume="124" first="125" last="132">
<title>Isolation of an evolutionarily conserved epidermal growth factor receptor cDNA from human A431 carcinoma cells.</title>
<authorList>
<person name="Simmen F.A."/>
<person name="Gope M.L."/>
<person name="Schulz T.Z."/>
<person name="Wright D.A."/>
<person name="Carpenter G."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="6093780"/>
<dbReference type="DOI" id="10.1016/0006-291X(84)90926-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1028-1210</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1987" name="Oncogene Res." volume="1" first="375" last="396">
<title>The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription.</title>
<authorList>
<person name="Haley J.D."/>
<person name="Whittle N."/>
<person name="Bennett P."/>
<person name="Kinchington D."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="3329716"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="1746" last="1753">
<title>Contributory effects of de novo transcription and premature transcript termination in the regulation of human epidermal growth factor receptor proto-oncogene RNA synthesis.</title>
<authorList>
<person name="Haley J.D."/>
<person name="Waterfield M.D."/>
</authorList>
<dbReference type="PubMed" id="1988448"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="4920" last="4924">
<title>Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.</title>
<authorList>
<person name="Ishii S."/>
<person name="Xu Y.H."/>
<person name="Stratton R.H."/>
<person name="Roe B.A."/>
<person name="Merlino G.T."/>
<person name="Pastan I."/>
</authorList>
<dbReference type="PubMed" id="2991899"/>
<dbReference type="DOI" id="10.1073/pnas.82.15.4920"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-29</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1984" name="Science" volume="224" first="294" last="297">
<title>Production of an epidermal growth factor receptor-related protein.</title>
<authorList>
<person name="Weber W."/>
<person name="Gill G.N."/>
<person name="Spiess J."/>
</authorList>
<dbReference type="PubMed" id="6324343"/>
<dbReference type="DOI" id="10.1126/science.6324343"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 25-49</scope>
</reference>
<reference key="16">
<citation type="submission" date="1997-09" db="UniProtKB">
<authorList>
<person name="Kohda D."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 540</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="13152" last="13158">
<title>Epidermal growth factor receptor threonine and serine residues phosphorylated in vivo.</title>
<authorList>
<person name="Heisermann G.J."/>
<person name="Gill G.N."/>
</authorList>
<dbReference type="PubMed" id="3138233"/>
</citation>
<scope>PROTEIN SEQUENCE OF 687-705; 986-998; 1000-1023; 1026-1030 AND 1068-1077</scope>
<scope>PHOSPHORYLATION AT THR-693; SER-695; SER-1070 AND SER-1071</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
<title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
<authorList>
<person name="Zhang Z."/>
<person name="Henzel W.J."/>
</authorList>
<dbReference type="PubMed" id="15340161"/>
<dbReference type="DOI" id="10.1110/ps.04682504"/>
</citation>
<scope>PROTEIN SEQUENCE OF 25-39</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1985" name="J. Biol. Chem." volume="260" first="5205" last="5208">
<title>Identification of residues in the nucleotide binding site of the epidermal growth factor receptor/kinase.</title>
<authorList>
<person name="Russo M.W."/>
<person name="Lukas T.J."/>
<person name="Cohen S."/>
<person name="Staros J.V."/>
</authorList>
<dbReference type="PubMed" id="2985580"/>
</citation>
<scope>PROTEIN SEQUENCE OF 740-744 AND 746-747</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Mol. Cell" volume="21" first="737" last="748">
<title>Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain.</title>
<authorList>
<person name="Huang F."/>
<person name="Kirkpatrick D."/>
<person name="Jiang X."/>
<person name="Gygi S.P."/>
<person name="Sorkin A."/>
</authorList>
<dbReference type="PubMed" id="16543144"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.02.018"/>
</citation>
<scope>PROTEIN SEQUENCE OF 861-875 AND 914-932</scope>
<scope>UBIQUITINATION AT LYS-716; LYS-737; LYS-754; LYS-867; LYS-929 AND LYS-970</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="11150" last="11157">
<title>Disulfide bond structure of human epidermal growth factor receptor.</title>
<authorList>
<person name="Abe Y."/>
<person name="Odaka M."/>
<person name="Inagaki F."/>
<person name="Lax I."/>
<person name="Schlessinger J."/>
<person name="Kohda D."/>
</authorList>
<dbReference type="PubMed" id="9556602"/>
<dbReference type="DOI" id="10.1074/jbc.273.18.11150"/>
</citation>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1984" name="Nature" volume="309" first="270" last="273">
<title>ATP-stimulated interaction between epidermal growth factor receptor and supercoiled DNA.</title>
<authorList>
<person name="Mroczkowski B."/>
<person name="Mosig G."/>
<person name="Cohen S."/>
</authorList>
<dbReference type="PubMed" id="6325948"/>
<dbReference type="DOI" id="10.1038/309270a0"/>
</citation>
<scope>RECEPTOR ACTIVITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1987" name="Annu. Rev. Biochem." volume="56" first="881" last="914">
<title>Receptors for epidermal growth factor and other polypeptide mitogens.</title>
<authorList>
<person name="Carpenter G."/>
</authorList>
<dbReference type="PubMed" id="3039909"/>
<dbReference type="DOI" id="10.1146/annurev.bi.56.070187.004313"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1989" name="Cell" volume="59" first="33" last="43">
<title>Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulation.</title>
<authorList>
<person name="Chen W.S."/>
<person name="Lazar C.S."/>
<person name="Lund K.A."/>
<person name="Welsh J.B."/>
<person name="Chang C.P."/>
<person name="Walton G.M."/>
<person name="Der C.J."/>
<person name="Wiley H.S."/>
<person name="Gill G.N."/>
<person name="Rosenfeld M.G."/>
</authorList>
<dbReference type="PubMed" id="2790960"/>
<dbReference type="DOI" id="10.1016/0092-8674(89)90867-2"/>
</citation>
<scope>LIGAND-BINDING</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1989" name="J. Biol. Chem." volume="264" first="10667" last="10671">
<title>All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor.</title>
<authorList>
<person name="Margolis B.L."/>
<person name="Lax I."/>
<person name="Kris R."/>
<person name="Dombalagian M."/>
<person name="Honegger A.M."/>
<person name="Howk R."/>
<person name="Givol D."/>
<person name="Ullrich A."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="2543678"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1110</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="2924" last="2931">
<title>Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells.</title>
<authorList>
<person name="Johnson G.R."/>
<person name="Kannan B."/>
<person name="Shoyab M."/>
<person name="Stromberg K."/>
</authorList>
<dbReference type="PubMed" id="7679104"/>
</citation>
<scope>IDENTIFICATION OF AMPHIREGULIN AS LIGAND</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1996" name="Science" volume="272" first="1797" last="1802">
<title>Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor.</title>
<authorList>
<person name="Galcheva-Gargova Z."/>
<person name="Konstantinov K.N."/>
<person name="Wu I.-H."/>
<person name="Klier F.G."/>
<person name="Barrett T."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="8650580"/>
<dbReference type="DOI" id="10.1126/science.272.5269.1797"/>
</citation>
<scope>INTERACTION WITH ZPR1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1998" name="J. Cell Biol." volume="143" first="1471" last="1484">
<title>Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells.</title>
<authorList>
<person name="Gangwani L."/>
<person name="Mikrut M."/>
<person name="Galcheva-Gargova Z."/>
<person name="Davis R.J."/>
</authorList>
<dbReference type="PubMed" id="9852145"/>
<dbReference type="DOI" id="10.1083/jcb.143.6.1471"/>
</citation>
<scope>INTERACTION WITH ZPR1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="5567" last="5576">
<title>Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor.</title>
<authorList>
<person name="Bagowski C.P."/>
<person name="Stein-Gerlach M."/>
<person name="Choidas A."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="10523301"/>
<dbReference type="DOI" id="10.1093/emboj/18.20.5567"/>
</citation>
<scope>PHOSPHORYLATION AT THR-678 AND THR-693</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="9966" last="9973">
<title>Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction.</title>
<authorList>
<person name="Watanabe T."/>
<person name="Shintani A."/>
<person name="Nakata M."/>
<person name="Shing Y."/>
<person name="Folkman J."/>
<person name="Igarashi K."/>
<person name="Sasada R."/>
</authorList>
<dbReference type="PubMed" id="8144591"/>
</citation>
<scope>IDENTIFICATION OF BETACELLULIN/BTC AS LIGAND</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="20242" last="20245">
<title>Tyrosine phosphorylation of the c-cbl proto-oncogene protein product and association with epidermal growth factor (EGF) receptor upon EGF stimulation.</title>
<authorList>
<person name="Galisteo M.L."/>
<person name="Dikic I."/>
<person name="Batzer A.G."/>
<person name="Langdon W.Y."/>
<person name="Schlessinger J."/>
</authorList>
<dbReference type="PubMed" id="7657591"/>
<dbReference type="DOI" id="10.1074/jbc.270.35.20242"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF CBL</scope>
<scope>INTERACTION WITH CBL</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1996" name="Growth Factors" volume="13" first="121" last="132">
<title>Analysis of the glycosylation patterns of the extracellular domain of the epidermal growth factor receptor expressed in Chinese hamster ovary fibroblasts.</title>
<authorList>
<person name="Smith K.D."/>
<person name="Davies M.J."/>
<person name="Bailey D."/>
<person name="Renouf D.V."/>
<person name="Hounsell E.F."/>
</authorList>
<dbReference type="PubMed" id="8962717"/>
<dbReference type="DOI" id="10.3109/08977199609034572"/>
</citation>
<scope>GLYCOSYLATION AT ASN-128; ASN-175; ASN-413; ASN-444 AND ASN-528</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1997" name="Oncogene" volume="15" first="2841" last="2848">
<title>Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.</title>
<authorList>
<person name="Komurasaki T."/>
<person name="Toyoda H."/>
<person name="Uchida D."/>
<person name="Morimoto S."/>
</authorList>
<dbReference type="PubMed" id="9419975"/>
<dbReference type="DOI" id="10.1038/sj.onc.1201458"/>
</citation>
<scope>IDENTIFICATION OF EPIREGULIN/EREG AS LIGAND</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Mol. Cell. Biol." volume="18" first="1622" last="1634">
<title>Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase.</title>
<authorList>
<person name="Tiganis T."/>
<person name="Bennett A.M."/>
<person name="Ravichandran K.S."/>
<person name="Tonks N.K."/>
</authorList>
<dbReference type="PubMed" id="9488479"/>
<dbReference type="DOI" id="10.1128/MCB.18.3.1622"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DEPHOSPHORYLATION BY PTPN1 AND PTPN2</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="2489" last="2499">
<title>Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis.</title>
<authorList>
<person name="Nesterov A."/>
<person name="Carter R.E."/>
<person name="Sorkina T."/>
<person name="Gill G.N."/>
<person name="Sorkin A."/>
</authorList>
<dbReference type="PubMed" id="10228163"/>
<dbReference type="DOI" id="10.1093/emboj/18.9.2489"/>
</citation>
<scope>INTERACTION WITH AP2M1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="5542" last="5549">
<title>Identification of Grb4/Nckbeta, a src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck.</title>
<authorList>
<person name="Braverman L.E."/>
<person name="Quilliam L.A."/>
</authorList>
<dbReference type="PubMed" id="10026169"/>
<dbReference type="DOI" id="10.1074/jbc.274.9.5542"/>
</citation>
<scope>INTERACTION WITH GRB2; NCK1 AND NCK2</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2000" name="J. Biochem." volume="127" first="65" last="72">
<title>Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor.</title>
<authorList>
<person name="Sato C."/>
<person name="Kim J.-H."/>
<person name="Abe Y."/>
<person name="Saito K."/>
<person name="Yokoyama S."/>
<person name="Kohda D."/>
</authorList>
<dbReference type="PubMed" id="10731668"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a022585"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-352; ASN-361; ASN-568 AND ASN-603</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="48532" last="48538">
<title>RGS16 function is regulated by epidermal growth factor receptor-mediated tyrosine phosphorylation.</title>
<authorList>
<person name="Derrien A."/>
<person name="Druey K.M."/>
</authorList>
<dbReference type="PubMed" id="11602604"/>
<dbReference type="DOI" id="10.1074/jbc.M108862200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF RGS16</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="5478" last="5492">
<title>Characterization of glycosylation sites of the epidermal growth factor receptor.</title>
<authorList>
<person name="Zhen Y."/>
<person name="Caprioli R.M."/>
<person name="Staros J.V."/>
</authorList>
<dbReference type="PubMed" id="12731890"/>
<dbReference type="DOI" id="10.1021/bi027101p"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361; ASN-413; ASN-444; ASN-528; ASN-568; ASN-603 AND ASN-623</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="Cancer Res." volume="63" first="3923" last="3930">
<title>Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.</title>
<authorList>
<person name="Shao H."/>
<person name="Cheng H.Y."/>
<person name="Cook R.G."/>
<person name="Tweardy D.J."/>
</authorList>
<dbReference type="PubMed" id="12873986"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>INTERACTION WITH STAT3</scope>
<scope>PHOSPHORYLATION AT TYR-1092 AND TYR-1110</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="3270" last="3281">
<title>LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation.</title>
<authorList>
<person name="Gur G."/>
<person name="Rubin C."/>
<person name="Katz M."/>
<person name="Amit I."/>
<person name="Citri A."/>
<person name="Nilsson J."/>
<person name="Amariglio N."/>
<person name="Henriksson R."/>
<person name="Rechavi G."/>
<person name="Hedman H."/>
<person name="Wides R."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15282549"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600342"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH LRIG1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3817" last="3830">
<title>Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.</title>
<authorList>
<person name="Arcaro A."/>
<person name="Zvelebil M.J."/>
<person name="Wallasch C."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
<person name="Domin J."/>
</authorList>
<dbReference type="PubMed" id="10805725"/>
<dbReference type="DOI" id="10.1128/MCB.20.11.3817-3830.2000"/>
</citation>
<scope>FUNCTION IN EGFR SIGNALING</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2A AND ERBB2</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2B AND ERBB2</scope>
<scope>INTERACTION WITH PIK3C2B</scope>
<scope>MUTAGENESIS OF TYR-1016; TYR-1092; TYR-1110; TYR-1172 AND TYR-1197</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8865" last="8874">
<title>The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome.</title>
<authorList>
<person name="Habib A.A."/>
<person name="Chatterjee S."/>
<person name="Park S.-K."/>
<person name="Ratan R.R."/>
<person name="Lefebvre S."/>
<person name="Vartanian T."/>
</authorList>
<dbReference type="PubMed" id="11116146"/>
<dbReference type="DOI" id="10.1074/jbc.M008458200"/>
</citation>
<scope>FUNCTION IN NF-KAPPA-B ACTIVATION</scope>
<scope>INTERACTION WITH RIPK1</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="35239" last="35242">
<title>The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin.</title>
<authorList>
<person name="Li Y."/>
<person name="Ren J."/>
<person name="Yu W."/>
<person name="Li Q."/>
<person name="Kuwahara H."/>
<person name="Yin L."/>
<person name="Carraway K.L. III"/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="11483589"/>
<dbReference type="DOI" id="10.1074/jbc.C100359200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MUC1</scope>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="7038" last="7048">
<title>Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling.</title>
<authorList>
<person name="Kario E."/>
<person name="Marmor M.D."/>
<person name="Adamsky K."/>
<person name="Citri A."/>
<person name="Amit I."/>
<person name="Amariglio N."/>
<person name="Rechavi G."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15590694"/>
<dbReference type="DOI" id="10.1074/jbc.M408575200"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH SOCS5</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="8503" last="8512">
<title>Epigen, the last ligand of ErbB receptors, reveals intricate relationships between affinity and mitogenicity.</title>
<authorList>
<person name="Kochupurakkal B.S."/>
<person name="Harari D."/>
<person name="Di-Segni A."/>
<person name="Maik-Rachline G."/>
<person name="Lyass L."/>
<person name="Gur G."/>
<person name="Kerber G."/>
<person name="Citri A."/>
<person name="Lavi S."/>
<person name="Eilam R."/>
<person name="Chalifa-Caspi V."/>
<person name="Eshhar Z."/>
<person name="Pikarsky E."/>
<person name="Pinkas-Kramarski R."/>
<person name="Bacus S.S."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="15611079"/>
<dbReference type="DOI" id="10.1074/jbc.M413919200"/>
</citation>
<scope>IDENTIFICATION OF EPIGEN/EPGN AS A LIGAND</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2005" name="J. Proteome Res." volume="4" first="1155" last="1170">
<title>Extended Range Proteomic Analysis (ERPA): a new and sensitive LC-MS platform for high sequence coverage of complex proteins with extensive post-translational modifications-comprehensive analysis of beta-casein and epidermal growth factor receptor (EGFR).</title>
<authorList>
<person name="Wu S.L."/>
<person name="Kim J."/>
<person name="Hancock W.S."/>
<person name="Karger B."/>
</authorList>
<dbReference type="PubMed" id="16083266"/>
<dbReference type="DOI" id="10.1021/pr050113n"/>
</citation>
<scope>GLYCOSYLATION AT ASN-56; ASN-128; ASN-175; ASN-196; ASN-352; ASN-361; ASN-413; ASN-444; ASN-528; ASN-568 AND ASN-603</scope>
<scope>PHOSPHORYLATION AT THR-693; SER-991 AND SER-1026</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2005" name="Cancer Res." volume="65" first="7724" last="7732">
<title>Functional implications of altered subcellular localization of PELP1 in breast cancer cells.</title>
<authorList>
<person name="Vadlamudi R.K."/>
<person name="Manavathi B."/>
<person name="Balasenthil S."/>
<person name="Nair S.S."/>
<person name="Yang Z."/>
<person name="Sahin A.A."/>
<person name="Kumar R."/>
</authorList>
<dbReference type="PubMed" id="16140940"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-05-0614"/>
</citation>
<scope>INTERACTION WITH PELP1</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1172 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2006" name="Nat. Cell Biol." volume="8" first="1359" last="1368">
<title>Tyrosine phosphorylation controls PCNA function through protein stability.</title>
<authorList>
<person name="Wang S.C."/>
<person name="Nakajima Y."/>
<person name="Yu Y.L."/>
<person name="Xia W."/>
<person name="Chen C.T."/>
<person name="Yang C.C."/>
<person name="McIntush E.W."/>
<person name="Li L.Y."/>
<person name="Hawke D.H."/>
<person name="Kobayashi R."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="17115032"/>
<dbReference type="DOI" id="10.1038/ncb1501"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION</scope>
<scope>FUNCTION IN PCNA PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PCNA</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2007" name="J. Clin. Invest." volume="117" first="2260" last="2267">
<title>Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia.</title>
<authorList>
<person name="Groenestege W.M.T."/>
<person name="Thebault S."/>
<person name="van der Wijst J."/>
<person name="van den Berg D."/>
<person name="Janssen R."/>
<person name="Tejpar S."/>
<person name="van den Heuvel L.P."/>
<person name="van Cutsem E."/>
<person name="Hoenderop J.G."/>
<person name="Knoers N.V."/>
<person name="Bindels R.J."/>
</authorList>
<dbReference type="PubMed" id="17671655"/>
<dbReference type="DOI" id="10.1172/JCI31680"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2007" name="Mol. Biol. Cell" volume="18" first="732" last="742">
<title>Activated Cdc42-associated kinase 1 is a component of EGF receptor signaling complex and regulates EGF receptor degradation.</title>
<authorList>
<person name="Shen F."/>
<person name="Lin Q."/>
<person name="Gu Y."/>
<person name="Childress C."/>
<person name="Yang W."/>
</authorList>
<dbReference type="PubMed" id="17182860"/>
<dbReference type="DOI" id="10.1091/mbc.E06-02-0142"/>
</citation>
<scope>INTERACTION WITH TNF2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2008" name="Cell. Signal." volume="20" first="1725" last="1739">
<title>Ataxin-2 associates with the endocytosis complex and affects EGF receptor trafficking.</title>
<authorList>
<person name="Nonis D."/>
<person name="Schmidt M.H."/>
<person name="van de Loo S."/>
<person name="Eich F."/>
<person name="Dikic I."/>
<person name="Nowock J."/>
<person name="Auburger G."/>
</authorList>
<dbReference type="PubMed" id="18602463"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2008.05.018"/>
</citation>
<scope>INTERACTION WITH ATX2</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2008" name="EMBO J." volume="27" first="2305" last="2316">
<title>Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.</title>
<authorList>
<person name="Brummer T."/>
<person name="Larance M."/>
<person name="Herrera Abreu M.T."/>
<person name="Lyons R.J."/>
<person name="Timpson P."/>
<person name="Emmerich C.H."/>
<person name="Fleuren E.D.G."/>
<person name="Lehrbach G.M."/>
<person name="Schramek D."/>
<person name="Guilhaus M."/>
<person name="James D.E."/>
<person name="Daly R.J."/>
</authorList>
<dbReference type="PubMed" id="19172738"/>
<dbReference type="DOI" id="10.1038/emboj.2008.159"/>
</citation>
<scope>INTERACTION WITH GAB2</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="56">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-695; SER-1064; SER-1081; SER-1166 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="57">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-991; SER-995; TYR-998; SER-1039; THR-1041; SER-1042; SER-1064 AND SER-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="58">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2009" name="Curr. Biol." volume="19" first="1788" last="1798">
<title>An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.</title>
<authorList>
<person name="Tarcic G."/>
<person name="Boguslavsky S.K."/>
<person name="Wakim J."/>
<person name="Kiuchi T."/>
<person name="Liu A."/>
<person name="Reinitz F."/>
<person name="Nathanson D."/>
<person name="Takahashi T."/>
<person name="Mischel P.S."/>
<person name="Ng T."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="19836242"/>
<dbReference type="DOI" id="10.1016/j.cub.2009.09.048"/>
</citation>
<scope>ENZYME REGULATION BY PTPRJ AND PTPRK</scope>
<scope>PHOSPHORYLATION AT TYR-1197</scope>
<scope>DEPHOSPHORYLATION BY PTPRJ</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CBL AND GRB2</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="20206" last="20214">
<title>GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling.</title>
<authorList>
<person name="Tashiro K."/>
<person name="Tsunematsu T."/>
<person name="Okubo H."/>
<person name="Ohta T."/>
<person name="Sano E."/>
<person name="Yamauchi E."/>
<person name="Taniguchi H."/>
<person name="Konishi H."/>
</authorList>
<dbReference type="PubMed" id="19509291"/>
<dbReference type="DOI" id="10.1074/jbc.M109.021139"/>
</citation>
<scope>INTERACTION WITH GAREM1</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
<title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
<authorList>
<person name="Chen R."/>
<person name="Jiang X."/>
<person name="Sun D."/>
<person name="Han G."/>
<person name="Wang F."/>
<person name="Ye M."/>
<person name="Wang L."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="19159218"/>
<dbReference type="DOI" id="10.1021/pr8008012"/>
</citation>
<scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-352; ASN-413 AND ASN-568</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="62">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2009" name="Mol. Endocrinol." volume="23" first="1815" last="1826">
<title>G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells.</title>
<authorList>
<person name="Vivacqua A."/>
<person name="Lappano R."/>
<person name="De Marco P."/>
<person name="Sisci D."/>
<person name="Aquila S."/>
<person name="De Amicis F."/>
<person name="Fuqua S.A."/>
<person name="Ando S."/>
<person name="Maggiolini M."/>
</authorList>
<dbReference type="PubMed" id="19749156"/>
<dbReference type="DOI" id="10.1210/me.2009-0120"/>
</citation>
<scope>INTERACTION WITH GPER1</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2010" name="Biochem. Biophys. Res. Commun." volume="399" first="498" last="504">
<title>COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport.</title>
<authorList>
<person name="Wang Y.N."/>
<person name="Wang H."/>
<person name="Yamaguchi H."/>
<person name="Lee H.J."/>
<person name="Lee H.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="20674546"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2010.07.096"/>
</citation>
<scope>INTERACTION WITH COPG1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="6036" last="6046">
<title>Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts.</title>
<authorList>
<person name="Madeo A."/>
<person name="Maggiolini M."/>
</authorList>
<dbReference type="PubMed" id="20551055"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-0408"/>
</citation>
<scope>INTERACTION WITH GPER1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1064 AND TYR-1197</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="67">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="20558" last="20568">
<title>Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells.</title>
<authorList>
<person name="Huang W.C."/>
<person name="Chen Y.J."/>
<person name="Li L.Y."/>
<person name="Wei Y.L."/>
<person name="Hsu S.C."/>
<person name="Tsai S.L."/>
<person name="Chiu P.C."/>
<person name="Huang W.P."/>
<person name="Wang Y.N."/>
<person name="Chen C.H."/>
<person name="Chang W.C."/>
<person name="Chang W.C."/>
<person name="Chen A.J."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21487020"/>
<dbReference type="DOI" id="10.1074/jbc.M111.240796"/>
</citation>
<scope>PHOSPHORYLATION AT SER-229</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2011" name="Nat. Cell Biol." volume="13" first="174" last="181">
<title>Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation.</title>
<authorList>
<person name="Hsu J.M."/>
<person name="Chen C.T."/>
<person name="Chou C.K."/>
<person name="Kuo H.P."/>
<person name="Li L.Y."/>
<person name="Lin C.Y."/>
<person name="Lee H.J."/>
<person name="Wang Y.N."/>
<person name="Liu M."/>
<person name="Liao H.W."/>
<person name="Shi B."/>
<person name="Lai C.C."/>
<person name="Bedford M.T."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21258366"/>
<dbReference type="DOI" id="10.1038/ncb2158"/>
</citation>
<scope>FUNCTION IN CELL PROLIFERATION AND CELL MIGRATION</scope>
<scope>METHYLATION AT ARG-1199 BY PRMT5</scope>
<scope>INTERACTION WITH PRMT5 AND PTPN6</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2011" name="Nat. Med." volume="17" first="589" last="595">
<title>EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.</title>
<authorList>
<person name="Lupberger J."/>
<person name="Zeisel M.B."/>
<person name="Xiao F."/>
<person name="Thumann C."/>
<person name="Fofana I."/>
<person name="Zona L."/>
<person name="Davis C."/>
<person name="Mee C.J."/>
<person name="Turek M."/>
<person name="Gorke S."/>
<person name="Royer C."/>
<person name="Fischer B."/>
<person name="Zahid M.N."/>
<person name="Lavillette D."/>
<person name="Fresquet J."/>
<person name="Cosset F.L."/>
<person name="Rothenberg S.M."/>
<person name="Pietschmann T."/>
<person name="Patel A.H."/>
<person name="Pessaux P."/>
<person name="Doffoel M."/>
<person name="Raffelsberger W."/>
<person name="Poch O."/>
<person name="McKeating J.A."/>
<person name="Brino L."/>
<person name="Baumert T.F."/>
</authorList>
<dbReference type="PubMed" id="21516087"/>
<dbReference type="DOI" id="10.1038/nm.2341"/>
</citation>
<scope>FUNCTION (MICROBIAL INFECTION)</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="7968" last="7973">
<title>FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaB.</title>
<authorList>
<person name="Guo C."/>
<person name="Stark G.R."/>
</authorList>
<dbReference type="PubMed" id="21518868"/>
<dbReference type="DOI" id="10.1073/pnas.1105369108"/>
</citation>
<scope>INTERACTION WITH FER</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2012" name="Mol. Biol. Cell" volume="23" first="1343" last="1353">
<title>The Ankrd 13 family of UIM-bearing proteins regulates EGF receptor endocytosis from the plasma membrane.</title>
<authorList>
<person name="Tanno H."/>
<person name="Yamaguchi T."/>
<person name="Goto E."/>
<person name="Ishido S."/>
<person name="Komada M."/>
</authorList>
<dbReference type="PubMed" id="22298428"/>
<dbReference type="DOI" id="10.1091/mbc.E11-09-0817"/>
</citation>
<scope>INTERACTION WITH ANKRD13A; ANKRD13B AND ALKRD13D</scope>
<scope>UBIQUITINATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="4599" last="4608">
<title>Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression.</title>
<authorList>
<person name="Pareja F."/>
<person name="Ferraro D.A."/>
<person name="Rubin C."/>
<person name="Cohen-Dvashi H."/>
<person name="Zhang F."/>
<person name="Aulmann S."/>
<person name="Ben-Chetrit N."/>
<person name="Pines G."/>
<person name="Navon R."/>
<person name="Crosetto N."/>
<person name="Kostler W."/>
<person name="Carvalho S."/>
<person name="Lavi S."/>
<person name="Schmitt F."/>
<person name="Dikic I."/>
<person name="Yakhini Z."/>
<person name="Sinn P."/>
<person name="Mills G.B."/>
<person name="Yarden Y."/>
</authorList>
<dbReference type="PubMed" id="22179831"/>
<dbReference type="DOI" id="10.1038/onc.2011.587"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY OTUD7B</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2013" name="J. Cell Sci." volume="126" first="1366" last="1380">
<title>The E3 ubiquitin ligases RNF126 and Rabring7 regulate endosomal sorting of the epidermal growth factor receptor.</title>
<authorList>
<person name="Smith C.J."/>
<person name="Berry D.M."/>
<person name="McGlade C.J."/>
</authorList>
<dbReference type="PubMed" id="23418353"/>
<dbReference type="DOI" id="10.1242/jcs.116129"/>
</citation>
<scope>INTERACTION WITH RNF115 AND RNF126</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693 AND SER-1064</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="76">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-693; SER-991; SER-1026 AND SER-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="77">
<citation type="journal article" date="2014" name="Mol. Cancer" volume="13" first="233" last="233">
<title>EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.</title>
<authorList>
<person name="Lin X."/>
<person name="Zhong S."/>
<person name="Ye X."/>
<person name="Liao Y."/>
<person name="Yao F."/>
<person name="Yang X."/>
<person name="Sun B."/>
<person name="Zhang J."/>
<person name="Li Q."/>
<person name="Gao Y."/>
<person name="Wang Y."/>
<person name="Liu J."/>
<person name="Han B."/>
<person name="Chin Y.E."/>
<person name="Zhou B.P."/>
<person name="Deng J."/>
</authorList>
<dbReference type="PubMed" id="25311788"/>
<dbReference type="DOI" id="10.1186/1476-4598-13-233"/>
</citation>
<scope>INTERACTION WITH GPRC5A</scope>
</reference>
<reference key="78">
<citation type="journal article" date="2014" name="Oncogene" volume="33" first="3298" last="3306">
<title>Hyperactivation of EGFR and downstream effector phospholipase D1 by oncogenic FAM83B.</title>
<authorList>
<person name="Cipriano R."/>
<person name="Bryson B.L."/>
<person name="Miskimen K.L."/>
<person name="Bartel C.A."/>
<person name="Hernandez-Sanchez W."/>
<person name="Bruntz R.C."/>
<person name="Scott S.A."/>
<person name="Lindsley C.W."/>
<person name="Brown H.A."/>
<person name="Jackson M.W."/>
</authorList>
<dbReference type="PubMed" id="23912460"/>
<dbReference type="DOI" id="10.1038/onc.2013.293"/>
</citation>
<scope>INTERACTION WITH FAM83B</scope>
</reference>
<reference key="79">
<citation type="journal article" date="2017" name="Gene" volume="626" first="48" last="53">
<title>Beclin1 antagonizes LAPTM4B-mediated EGFR overactivation in gastric cancer cells.</title>
<authorList>
<person name="Tian M."/>
<person name="Chen Y."/>
<person name="Tian D."/>
<person name="Qiao X."/>
<person name="Ma Z."/>
<person name="Li J."/>
</authorList>
<dbReference type="PubMed" id="28479384"/>
<dbReference type="DOI" id="10.1016/j.gene.2017.05.006"/>
</citation>
<scope>INTERACTION WITH LAPTM4B</scope>
</reference>
<reference key="80">
<citation type="journal article" date="2002" name="Cell" volume="110" first="775" last="787">
<title>Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.</title>
<authorList>
<person name="Ogiso H."/>
<person name="Ishitani R."/>
<person name="Nureki O."/>
<person name="Fukai S."/>
<person name="Yamanaka M."/>
<person name="Kim J.H."/>
<person name="Saito K."/>
<person name="Sakamoto A."/>
<person name="Inoue M."/>
<person name="Shirouzu M."/>
<person name="Yokoyama S."/>
</authorList>
<dbReference type="PubMed" id="12297050"/>
<dbReference type="DOI" id="10.1016/S0092-8674(02)00963-7"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-646 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION IN MAPK1 AND/OR MAPK3 ACTIVATION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF TYR-275; PHE-287; ARG-309 AND ARG-429</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-56; ASN-175; ASN-196; ASN-352; ASN-361 AND ASN-444</scope>
</reference>
<reference key="81">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="507" last="517">
<title>EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.</title>
<authorList>
<person name="Ferguson K.M."/>
<person name="Berger M.B."/>
<person name="Mendrola J.M."/>
<person name="Cho H.S."/>
<person name="Leahy D.J."/>
<person name="Lemmon M.A."/>
</authorList>
<dbReference type="PubMed" id="12620237"/>
<dbReference type="DOI" id="10.1016/S1097-2765(03)00047-9"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 25-642 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF 587-ASP--HIS-590 AND LYS-609</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-352; ASN-361; ASN-444; ASN-528; ASN-568 AND ASN-603</scope>
</reference>
<reference key="82">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="6652" last="6659">
<title>A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells.</title>
<authorList>
<person name="Wood E.R."/>
<person name="Truesdale A.T."/>
<person name="McDonald O.B."/>
<person name="Yuan D."/>
<person name="Hassell A."/>
<person name="Dickerson S.H."/>
<person name="Ellis B."/>
<person name="Pennisi C."/>
<person name="Horne E."/>
<person name="Lackey K."/>
<person name="Alligood K.J."/>
<person name="Rusnak D.W."/>
<person name="Gilmer T.M."/>
<person name="Shewchuk L."/>
</authorList>
<dbReference type="PubMed" id="15374980"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-1168"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 695-1022 IN COMPLEX WITH GW572016</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="83">
<citation type="journal article" date="2005" name="Cancer Cell" volume="7" first="301" last="311">
<title>Structural basis for inhibition of the epidermal growth factor receptor by cetuximab.</title>
<authorList>
<person name="Li S."/>
<person name="Schmitz K.R."/>
<person name="Jeffrey P.D."/>
<person name="Wiltzius J.J."/>
<person name="Kussie P."/>
<person name="Ferguson K.M."/>
</authorList>
<dbReference type="PubMed" id="15837620"/>
<dbReference type="DOI" id="10.1016/j.ccr.2005.03.003"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 25-642 IN COMPLEX WITH CETUXIMAB</scope>
</reference>
<reference key="84">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="24043" last="24052">
<title>A structural model for the membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor.</title>
<authorList>
<person name="Choowongkomon K."/>
<person name="Carlin C.R."/>
<person name="Sonnichsen F.D."/>
</authorList>
<dbReference type="PubMed" id="15840573"/>
<dbReference type="DOI" id="10.1074/jbc.M502698200"/>
</citation>
<scope>STRUCTURE BY NMR OF 669-721</scope>
</reference>
<reference key="85">
<citation type="journal article" date="2007" name="Cancer Cell" volume="11" first="217" last="227">
<title>Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity.</title>
<authorList>
<person name="Yun C.H."/>
<person name="Boggon T.J."/>
<person name="Li Y."/>
<person name="Woo M.S."/>
<person name="Greulich H."/>
<person name="Meyerson M."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="17349580"/>
<dbReference type="DOI" id="10.1016/j.ccr.2006.12.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.47 ANGSTROMS) OF 696-1022 OF WILD-TYPE AND VARIANTS SER-719 AND ARG-858 IN COMPLEXES WITH ATP ANALOGS AND SYNTHETIC INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>CHARACTERIZATION OF VARIANTS SER-719 AND ARG-858</scope>
</reference>
<reference key="86">
<citation type="journal article" date="2007" name="Nature" volume="450" first="741" last="744">
<title>Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.</title>
<authorList>
<person name="Zhang X."/>
<person name="Pickin K.A."/>
<person name="Bose R."/>
<person name="Jura N."/>
<person name="Cole P.A."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="18046415"/>
<dbReference type="DOI" id="10.1038/nature05998"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.90 ANGSTROMS) OF 702-1022 IN COMPLEX WITH ERRFI1</scope>
<scope>ENZYME REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH ERRFI1</scope>
</reference>
<reference key="87">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="2070" last="2075">
<title>The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.</title>
<authorList>
<person name="Yun C.H."/>
<person name="Mengwasser K.E."/>
<person name="Toms A.V."/>
<person name="Woo M.S."/>
<person name="Greulich H."/>
<person name="Wong K.K."/>
<person name="Meyerson M."/>
<person name="Eck M.J."/>
</authorList>
<dbReference type="PubMed" id="18227510"/>
<dbReference type="DOI" id="10.1073/pnas.0709662105"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.05 ANGSTROMS) OF 695-1022 OF VARIANT MET-790</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>CHARACTERIZATION OF VARIANT MET-790</scope>
</reference>
<reference key="88">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1293" last="1307">
<title>Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.</title>
<authorList>
<person name="Jura N."/>
<person name="Endres N.F."/>
<person name="Engel K."/>
<person name="Deindl S."/>
<person name="Das R."/>
<person name="Lamers M.H."/>
<person name="Wemmer D.E."/>
<person name="Zhang X."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="19563760"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.04.025"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF 696-1022</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT TYR-998; TYR-1016 AND TYR-1197</scope>
<scope>MUTAGENESIS OF LEU-688; GLU-690; LEU-692; ARG-977 AND 1005-GLU-ASP-1006</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="89">
<citation type="journal article" date="2009" name="Mol. Cell" volume="34" first="641" last="651">
<title>The juxtamembrane region of the EGF receptor functions as an activation domain.</title>
<authorList>
<person name="Red Brewer M."/>
<person name="Choi S.H."/>
<person name="Alvarado D."/>
<person name="Moravcevic K."/>
<person name="Pozzi A."/>
<person name="Lemmon M.A."/>
<person name="Carpenter G."/>
</authorList>
<dbReference type="PubMed" id="19560417"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.04.034"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 669-1022 OF MUTANT MET-745</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LEU-688; VAL-689; GLU-690; LEU-692; THR-693; PRO-694; PRO-699; ASN-700; LEU-704; ARG-705; ILE-706 AND LYS-745</scope>
</reference>
<reference key="90">
<citation type="journal article" date="2010" name="J. Mol. Biol." volume="400" first="231" last="243">
<title>Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.</title>
<authorList>
<person name="Mineev K.S."/>
<person name="Bocharov E.V."/>
<person name="Pustovalova Y.E."/>
<person name="Bocharova O.V."/>
<person name="Chupin V.V."/>
<person name="Arseniev A.S."/>
</authorList>
<dbReference type="PubMed" id="20471394"/>
<dbReference type="DOI" id="10.1016/j.jmb.2010.05.016"/>
</citation>
<scope>STRUCTURE BY NMR OF 634-677 IN COMPLEX WITH ERBB2</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="91">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="5432" last="5443">
<title>Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor.</title>
<authorList>
<person name="Lu C."/>
<person name="Mi L.Z."/>
<person name="Grey M.J."/>
<person name="Zhu J."/>
<person name="Graef E."/>
<person name="Yokoyama S."/>
<person name="Springer T.A."/>
</authorList>
<dbReference type="PubMed" id="20837704"/>
<dbReference type="DOI" id="10.1128/MCB.00742-10"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.3 ANGSTROMS) OF 25-638 IN COMPLEX WITH EGF</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-56; ASN-73; ASN-175; ASN-196; ASN-352; ASN-361; ASN-444 AND ASN-528</scope>
</reference>
<reference key="92">
<citation type="submission" date="2010-10" db="PDB data bank">
<title>Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069 peptide.</title>
<authorList>
<consortium name="Structural genomics consortium"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.27 ANGSTROMS) OF 1066-1076 IN COMPLEX WITH CBLB</scope>
<scope>INTERACTION WITH CBLB</scope>
</reference>
<reference key="93">
<citation type="journal article" date="2012" name="J. Biochem." volume="152" first="487" last="495">
<title>Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.</title>
<authorList>
<person name="Takeshita K."/>
<person name="Tezuka T."/>
<person name="Isozaki Y."/>
<person name="Yamashita E."/>
<person name="Suzuki M."/>
<person name="Kim M."/>
<person name="Yamanashi Y."/>
<person name="Yamamoto T."/>
<person name="Nakagawa A."/>
</authorList>
<dbReference type="PubMed" id="22888118"/>
<dbReference type="DOI" id="10.1093/jb/mvs085"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.52 ANGSTROMS) OF 1062-1074 IN COMPLEX WITH CBLC</scope>
<scope>PHOSPHORYLATION AT TYR-1069</scope>
<scope>INTERACTION WITH CBLC</scope>
<scope>MUTAGENESIS OF GLN-1067; ARG-1068 AND TYR-1069</scope>
</reference>
<reference key="94">
<citation type="journal article" date="2004" name="Clin. Cancer Res." volume="10" first="8195" last="8203">
<title>High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan.</title>
<authorList>
<person name="Huang S.F."/>
<person name="Liu H.P."/>
<person name="Li L.H."/>
<person name="Ku Y.C."/>
<person name="Fu Y.N."/>
<person name="Tsai H.Y."/>
<person name="Chen Y.T."/>
<person name="Lin Y.F."/>
<person name="Chang W.C."/>
<person name="Kuo H.P."/>
<person name="Wu Y.C."/>
<person name="Chen Y.R."/>
<person name="Tsai S.F."/>
</authorList>
<dbReference type="PubMed" id="15623594"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-04-1245"/>
</citation>
<scope>VARIANTS ALA-709; GLY-709; CYS-719; SER-719; 746-GLU--ALA-750 DEL; 746-GLU--THR-751 DELINS ALA; 746-GLU--SER-752 DELINS ASP; 747-LEU--THR-751 DEL; ILE-768; MET-769; VAL-833; LEU-835; VAL-838; ARG-858 AND GLN-861</scope>
</reference>
<reference key="95">
<citation type="journal article" date="2004" name="Science" volume="304" first="1497" last="1500">
<title>EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.</title>
<authorList>
<person name="Paez J.G."/>
<person name="Janne P.A."/>
<person name="Lee J.C."/>
<person name="Tracy S."/>
<person name="Greulich H."/>
<person name="Gabriel S."/>
<person name="Herman P."/>
<person name="Kaye F.J."/>
<person name="Lindeman N."/>
<person name="Boggon T.J."/>
<person name="Naoki K."/>
<person name="Sasaki H."/>
<person name="Fujii Y."/>
<person name="Eck M.J."/>
<person name="Sellers W.R."/>
<person name="Johnson B.E."/>
<person name="Meyerson M."/>
</authorList>
<dbReference type="PubMed" id="15118125"/>
<dbReference type="DOI" id="10.1126/science.1099314"/>
</citation>
<scope>VARIANTS SER-719 AND ARG-858</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="96">
<citation type="journal article" date="2006" name="Clin. Cancer Res." volume="12" first="1647" last="1653">
<title>Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.</title>
<authorList>
<person name="Tam I.Y.S."/>
<person name="Chung L.P."/>
<person name="Suen W.S."/>
<person name="Wang E."/>
<person name="Wong M.C.M."/>
<person name="Ho K.K."/>
<person name="Lam W.K."/>
<person name="Chiu S.W."/>
<person name="Girard L."/>
<person name="Minna J.D."/>
<person name="Gazdar A.F."/>
<person name="Wong M.P."/>
</authorList>
<dbReference type="PubMed" id="16533793"/>
<dbReference type="DOI" id="10.1158/1078-0432.CCR-05-1981"/>
</citation>
<scope>VARIANTS ALA-709; LYS-709; ALA-719; ASP-719; CYS-719; SER-719; SER-724; LYS-734; GLU-746 DEL; PHE-747; 747-LEU--GLU-749 DEL; PRO-748; 752-SER--ILE-759 DEL; ARG-787; MET-790; VAL-833; LEU-834; MET-858; ARG-858; GLN-861 AND GLU-873</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="97">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="1205" last="1215">
<title>Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants.</title>
<authorList>
<person name="Chen Y.R."/>
<person name="Fu Y.N."/>
<person name="Lin C.H."/>
<person name="Yang S.T."/>
<person name="Hu S.F."/>
<person name="Chen Y.T."/>
<person name="Tsai S.F."/>
<person name="Huang S.F."/>
</authorList>
<dbReference type="PubMed" id="16205628"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209159"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS ALA-709; GLY-709; SER-719; ILE-768; VAL-833; LEU-835; VAL-838; ARG-858 AND GLN-861</scope>
</reference>
<reference key="98">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="7817" last="7822">
<title>Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors.</title>
<authorList>
<person name="Ji H."/>
<person name="Zhao X."/>
<person name="Yuza Y."/>
<person name="Shimamura T."/>
<person name="Li D."/>
<person name="Protopopov A."/>
<person name="Jung B.L."/>
<person name="McNamara K."/>
<person name="Xia H."/>
<person name="Glatt K.A."/>
<person name="Thomas R.K."/>
<person name="Sasaki H."/>
<person name="Horner J.W."/>
<person name="Eck M."/>
<person name="Mitchell A."/>
<person name="Sun Y."/>
<person name="Al-Hashem R."/>
<person name="Bronson R.T."/>
<person name="Rabindran S.K."/>
<person name="Discafani C.M."/>
<person name="Maher E."/>
<person name="Shapiro G.I."/>
<person name="Meyerson M."/>
<person name="Wong K.K."/>
</authorList>
<dbReference type="PubMed" id="16672372"/>
<dbReference type="DOI" id="10.1073/pnas.0510284103"/>
</citation>
<scope>VARIANT 30-VAL--ARG-297 DEL</scope>
<scope>POSSIBLE INVOLVEMENT IN LUNG CANCER</scope>
</reference>
<reference key="99">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] LYS-521; ARG-1034 AND VAL-1210</scope>
</reference>
<reference key="100">
<citation type="journal article" date="2014" name="J. Invest. Dermatol." volume="134" first="2570" last="2578">
<title>Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR.</title>
<authorList>
<person name="Campbell P."/>
<person name="Morton P.E."/>
<person name="Takeichi T."/>
<person name="Salam A."/>
<person name="Roberts N."/>
<person name="Proudfoot L.E."/>
<person name="Mellerio J.E."/>
<person name="Aminu K."/>
<person name="Wellington C."/>
<person name="Patil S.N."/>
<person name="Akiyama M."/>
<person name="Liu L."/>
<person name="McMillan J.R."/>
<person name="Aristodemou S."/>
<person name="Ishida-Yamamoto A."/>
<person name="Abdul-Wahab A."/>
<person name="Petrof G."/>
<person name="Fong K."/>
<person name="Harnchoowong S."/>
<person name="Stone K.L."/>
<person name="Harper J.I."/>
<person name="McLean W.H."/>
<person name="Simpson M.A."/>
<person name="Parsons M."/>
<person name="McGrath J.A."/>
</authorList>
<dbReference type="PubMed" id="24691054"/>
<dbReference type="DOI" id="10.1038/jid.2014.164"/>
</citation>
<scope>VARIANT NISBD2 ASP-428</scope>
<scope>CHARACTERIZATION OF VARIANT NISBD2 ASP-428</scope>
<scope>INVOLVEMENT IN NISBD2</scope>
</reference>
<comment type="function">
<text evidence="34">Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. Plays a role in enhancing learning and memory performance (By similarity).</text>
</comment>
<comment type="function">
<text>Isoform 2 may act as an antagonist of EGF action.</text>
</comment>
<comment type="function">
<text evidence="83">(Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry. Mediates HCV entry by promoting the formation of the CD81-CLDN1 receptor complexes that are essential for HCV entry and by enhancing membrane fusion of cells expressing HCV envelope glycoproteins.</text>
</comment>
<comment type="catalytic activity">
<text evidence="37 52 65 67 68 73 74">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="50 53 67 76">Endocytosis and inhibition of the activated EGFR by phosphatases like PTPRJ and PTPRK constitute immediate regulatory mechanisms. Upon EGF-binding phosphorylates EPS15 that regulates EGFR endocytosis and activity. Moreover, inducible feedback inhibitors including LRIG1, SOCS4, SOCS5 and ERRFI1 constitute alternative regulatory mechanisms for the EGFR signaling.</text>
</comment>
<comment type="subunit">
<text evidence="38 39 42 43 44 45 46 48 50 52 53 55 57 62 63 67 69 71 72 73 74 75 76 77 78 79 80 81 84 86 87 88 89 91 93 95 96 98 101">Binding of the ligand triggers homo- and/or heterodimerization of the receptor triggering its autophosphorylation. Heterodimer with ERBB2. Interacts with ERRFI1; inhibits dimerization of the kinase domain and autophosphorylation. Part of a complex with ERBB2 and either PIK3C2A or PIK3C2B. Interacts with GRB2; an adapter protein coupling the receptor to downstream signaling pathways. Interacts with GAB2; involved in signaling downstream of EGFR. Interacts with STAT3; mediates EGFR downstream signaling in cell proliferation. Interacts with RIPK1; involved in NF-kappa-B activation. Interacts (autophosphorylated) with CBL, CBLB and CBLC; involved in EGFR ubiquitination and regulation. Interacts with SOCS5; regulates EGFR degradation through ELOC- and ELOB-mediated ubiquitination and proteasomal degradation. Interacts with PRMT5; methylates EGFR and enhances interaction with PTPN6. Interacts (phosphorylated) with PTPN6; inhibits EGFR-dependent activation of MAPK/ERK. Interacts with COPG1; essential for regulation of EGF-dependent nuclear transport of EGFR by retrograde trafficking from the Golgi to the ER. Interacts with TNK2; this interaction is dependent on EGF stimulation and kinase activity of EGFR. Interacts with PCNA; positively regulates PCNA. Interacts with PELP1. Interacts with MUC1. Interacts with AP2M1. Interacts with FER. May interact with EPS8; mediates EPS8 phosphorylation. Interacts (via SH2 domains) with GRB2, NCK1 and NCK2. Interacts with ATX2. Interacts with GAREM1. Interacts (ubiquitinated) with ANKRD13A/B/D; the interaction is direct and may regulate EGFR internalization after EGF stimulation. Interacts with GPER1; the interaction occurs in an estrogen-dependent manner. Interacts (via C-terminal cytoplasmic kinase domain) with ZPR1 (via zinc fingers). Interacts with RNF115 and RNF126. Interacts with GPRC5A (via its transmembrane domain)(PubMed:25311788). Interacts with FAM83B; positively regulates EGFR inducing its autophospharylation in absence of stimulation by EGF (PubMed:23912460). Interacts with LAPTM4B; positively correlates with EGFR activation (PubMed:28479384).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297353"/>
<organismsDiffer>false</organismsDiffer>
<experiments>30</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356749">
<id>Q53FC7</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356686">
<id>Q96BE0</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1646426">
<id>Q15109</id>
<label>AGER</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-528269">
<id>Q9UKV8</id>
<label>AGO2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2555881">
<id>Q09666</id>
<label>AHNAK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2562430">
<id>Q02952</id>
<label>AKAP12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1048612">
<id>Q92625</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297683">
<id>Q96CW1</id>
<label>AP2M1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-81694">
<id>O00213</id>
<label>APBB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79277">
<id>Q92870</id>
<label>APBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-286427">
<id>O95704</id>
<label>APBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-741243">
<id>Q9UKG1</id>
<label>APPL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-448680">
<id>O14965</id>
<label>AURKA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2850927">
<id>P30530</id>
<label>AXL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-949378">
<id>Q14457</id>
<label>BECN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2105445">
<id>P51451</id>
<label>BLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-397435">
<id>P62158</id>
<label>CALM3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-397530">
<id>P62161</id>
<label>Calm3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1748958">
<id>P49069</id>
<label>CAMLG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-603614">
<id>Q03135</id>
<label>CAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-518228">
<id>P22681</id>
<label>CBL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-640919">
<id>P22682</id>
<label>Cbl</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-727477">
<id>P12830</id>
<label>CDH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-617866">
<id>Q9NSE2</id>
<label>CISH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7878194">
<id>Q7Z7G1</id>
<label>CLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-886">
<id>P46108</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-287556">
<id>P46108-1</id>
<label>CRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-701918">
<id>P35221</id>
<label>CTNNA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-701927">
<id>O60716</id>
<label>CTNND1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-351886">
<id>Q14247</id>
<label>CTTN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-448974">
<id>Q99418</id>
<label>CYTH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2880244">
<id>Q6PKX4</id>
<label>DOK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-640857">
<id>P01133</id>
<label>EGF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-375576">
<id>Q12929</id>
<label>EPS8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-750962">
<id>P07992</id>
<label>ERCC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2941912">
<id>Q9UJM3</id>
<label>ERRFI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-4309277">
<id>P03372-4</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-355383">
<id>Q96A65</id>
<label>EXOC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-724839">
<id>Q14318</id>
<label>FKBP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-720116">
<id>P60520</id>
<label>GABARAPL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-354056">
<id>P04406</id>
<label>GAPDH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-712073">
<id>Q8NBJ4</id>
<label>GOLM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7250369">
<id>Q14956</id>
<label>GPNMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-16191078">
<id>Q14956-1</id>
<label>GPNMB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-740418">
<id>O75791</id>
<label>GRAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>36</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346340">
<id>P08631</id>
<label>HCK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-301697">
<id>Q9UBN7</id>
<label>HDAC6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1048378">
<id>Q8WUI4</id>
<label>HDAC7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9356629">
<id>Q6PK50</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-629985">
<id>P08107</id>
<label>HSPA1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-351896">
<id>P11142</id>
<label>HSPA8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-354932">
<id>P38646</id>
<label>HSPA9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-352682">
<id>P04792</id>
<label>HSPB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-715709">
<id>P17936</id>
<label>IGFBP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-356594">
<id>O14654</id>
<label>IRS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3267258">
<id>Q86VI4</id>
<label>LAPTM4B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1222766">
<id>O43561</id>
<label>LAT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346946">
<id>Q13094</id>
<label>LCP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-719955">
<id>Q96FE5</id>
<label>LINGO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1050422">
<id>Q38SD2</id>
<label>LRRK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79452">
<id>P07948</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-6895930">
<id>P07948-1</id>
<label>LYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
<label>MAPK8IP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-722813">
<id>Q13387</id>
<label>MAPK8IP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3385920">
<id>Q9Y2H9</id>
<label>MAST1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-372712">
<id>P14174</id>
<label>MIF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2804728">
<id>P15941</id>
<label>MUC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-389883">
<id>P16333</id>
<label>NCK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-493507">
<id>P04150</id>
<label>NR3C1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2861522">
<id>P16234</id>
<label>PDGFRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-641107">
<id>O00750</id>
<label>PIK3C2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1383528">
<id>P17252</id>
<label>PRKCA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2272005">
<id>P97313</id>
<label>Prkdc</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-916819">
<id>P20417</id>
<label>Ptpn1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1211241">
<id>Q9Y2R2</id>
<label>PTPN22</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-913954">
<id>Q9UJ41</id>
<label>RABGEF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3940924">
<id>Q70E73</id>
<label>RAPH1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-366017">
<id>Q13671</id>
<label>RIN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-6082337">
<id>Q01973</id>
<label>ROR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2952709">
<id>Q92622</id>
<label>RUBCN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-3506572">
<id>Q80U62</id>
<label>Rubcn</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-476295">
<id>P31947</id>
<label>SFN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-310491">
<id>Q9NRF2</id>
<label>SH2B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7879749">
<id>Q9UQQ2</id>
<label>SH2B3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2339271">
<id>Q9BRG2</id>
<label>SH2D3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>28</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9691288">
<id>P29353-7</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-7256023">
<id>P98077</id>
<label>SHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-9453524">
<id>Q6S5L8</id>
<label>SHC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-726214">
<id>Q13239</id>
<label>SLA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1772443">
<id>P13866</id>
<label>SLC5A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-749537">
<id>P42229</id>
<label>STAT5A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1054052">
<id>P31948</id>
<label>STIP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-357085">
<id>Q9UNE7</id>
<label>STUB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1034374">
<id>P01135</id>
<label>TGFA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2462036">
<id>Q9Y490</id>
<label>TLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-973722">
<id>O60603</id>
<label>TLR2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-712991">
<id>O75674</id>
<label>TOM1L1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-2650739">
<id>Q8K424</id>
<label>Trpv3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-302552">
<id>Q71U36</id>
<label>TUBA1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-594644">
<id>P10599</id>
<label>TXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-714860">
<id>P09936</id>
<label>UCHL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1059156">
<id>Q9P0L0</id>
<label>VAPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-515331">
<id>P07947</id>
<label>YES1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-359854">
<id>P27348</id>
<label>YWHAQ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297353"/>
<interactant intactId="EBI-1211276">
<id>P43403</id>
<label>ZAP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Endoplasmic reticulum membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Golgi apparatus membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Endosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Endosome membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>In response to EGF, translocated from the cell membrane to the nucleus via Golgi and ER. Endocytosed upon activation by ligand. Colocalized with GPER1 in the nucleus of estrogen agonist-induced cancer-associated fibroblasts (CAF).</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P00533-1</id>
<name>1</name>
<name>p170</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P00533-2</id>
<name>2</name>
<name>p60</name>
<name>Truncated</name>
<name>TEGFR</name>
<sequence type="described" ref="VSP_002887 VSP_002888"/>
</isoform>
<isoform>
<id>P00533-3</id>
<name>3</name>
<name>p110</name>
<sequence type="described" ref="VSP_002889 VSP_002890"/>
</isoform>
<isoform>
<id>P00533-4</id>
<name>4</name>
<sequence type="described" ref="VSP_002891 VSP_002892"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="66">Ubiquitously expressed. Isoform 2 is also expressed in ovarian cancers.</text>
</comment>
<comment type="PTM">
<text evidence="40 48 56 74 76 81 92 94">Phosphorylation at Ser-695 is partial and occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by PTPN1 and PTPN2.</text>
</comment>
<comment type="PTM">
<text evidence="34 60 85 86">Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting. Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occurs. Deubiquitination by OTUD7B prevents degradation. Ubiquitinated by RNF115 and RNF126 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="74 76 81">Methylated. Methylation at Arg-1199 by PRMT5 stimulates phosphorylation at Tyr-1197.</text>
</comment>
<comment type="disease" evidence="49 59 61">
<disease id="DI-02205">
<name>Lung cancer</name>
<acronym>LNCR</acronym>
<description>A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.</description>
<dbReference type="MIM" id="211980"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="90">
<disease id="DI-04271">
<name>Inflammatory skin and bowel disease, neonatal, 2</name>
<acronym>NISBD2</acronym>
<description>A disorder characterized by inflammatory features with neonatal onset, involving the skin, hair, and gut. The skin lesions involve perioral and perianal erythema, psoriasiform erythroderma, with flares of erythema, scaling, and widespread pustules. Gastrointestinal symptoms include malabsorptive diarrhea that is exacerbated by intercurrent gastrointestinal infections. The hair is short or broken, and the eyelashes and eyebrows are wiry and disorganized.</description>
<dbReference type="MIM" id="616069"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="36">Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/egfr/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor"/>
<text>EGFR entry</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="X00588">
<property type="protein sequence ID" value="CAA25240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U95089">
<property type="protein sequence ID" value="AAB53063.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U48722">
<property type="protein sequence ID" value="AAC50802.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U48723">
<property type="protein sequence ID" value="AAC50804.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48724">
<property type="protein sequence ID" value="AAC50796.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48725">
<property type="protein sequence ID" value="AAC50797.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48726">
<property type="protein sequence ID" value="AAC50798.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48727">
<property type="protein sequence ID" value="AAC50799.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48728">
<property type="protein sequence ID" value="AAC50800.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U48729">
<property type="protein sequence ID" value="AAC50801.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35786.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35787.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35788.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35789.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF288738">
<property type="protein sequence ID" value="AAG35790.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY698024">
<property type="protein sequence ID" value="AAT97979.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY588246">
<property type="protein sequence ID" value="AAS83109.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF277897">
<property type="protein sequence ID" value="AAK01080.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125253">
<property type="protein sequence ID" value="AAG43240.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125539">
<property type="protein sequence ID" value="AAG43243.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF125538">
<property type="protein sequence ID" value="AAG43243.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X06370">
<property type="protein sequence ID" value="CAA29668.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X00663">
<property type="protein sequence ID" value="CAA25282.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M38425">
<property type="protein sequence ID" value="AAA63171.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M11234">
<property type="protein sequence ID" value="AAA52370.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47587.1">
<molecule id="P00533-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5514.1">
<molecule id="P00533-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5515.1">
<molecule id="P00533-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5516.1">
<molecule id="P00533-4"/>
</dbReference>
<dbReference type="PIR" id="A00641">
<property type="entry name" value="GQHUE"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005219.2">
<molecule id="P00533-1"/>
<property type="nucleotide sequence ID" value="NM_005228.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958439.1">
<molecule id="P00533-4"/>
<property type="nucleotide sequence ID" value="NM_201282.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958440.1">
<molecule id="P00533-2"/>
<property type="nucleotide sequence ID" value="NM_201283.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_958441.1">
<molecule id="P00533-3"/>
<property type="nucleotide sequence ID" value="NM_201284.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.488293"/>
<dbReference type="UniGene" id="Hs.605083"/>
<dbReference type="UniGene" id="Hs.731652"/>
<dbReference type="PDB" id="1DNQ">
<property type="method" value="Model"/>
<property type="chains" value="A=25-336"/>
</dbReference>
<dbReference type="PDB" id="1DNR">
<property type="method" value="Model"/>
<property type="chains" value="A=337-645"/>
</dbReference>
<dbReference type="PDB" id="1IVO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=25-646"/>
</dbReference>
<dbReference type="PDB" id="1M14">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1M17">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1MOX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B=25-525"/>
</dbReference>
<dbReference type="PDB" id="1NQL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="1XKK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="1YY9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="1Z9I">
<property type="method" value="NMR"/>
<property type="chains" value="A=669-721"/>
</dbReference>
<dbReference type="PDB" id="2EB2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2EB3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.84"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2EXP">
<property type="method" value="Model"/>
<property type="chains" value="A=311-326"/>
</dbReference>
<dbReference type="PDB" id="2EXQ">
<property type="method" value="Model"/>
<property type="chains" value="A=27-536"/>
</dbReference>
<dbReference type="PDB" id="2GS2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2GS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2GS7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.74"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.47"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.88"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.42"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2ITZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.72"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J5E">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J5F">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2J6M">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIT">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2JIV">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="2KS1">
<property type="method" value="NMR"/>
<property type="chains" value="B=634-677"/>
</dbReference>
<dbReference type="PDB" id="2M0B">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=634-677"/>
</dbReference>
<dbReference type="PDB" id="2M20">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=642-697"/>
</dbReference>
<dbReference type="PDB" id="2N5S">
<property type="method" value="NMR"/>
<property type="chains" value="A=642-690"/>
</dbReference>
<dbReference type="PDB" id="2RF9">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="2RFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="A/B=702-1022"/>
</dbReference>
<dbReference type="PDB" id="2RFE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=702-1022"/>
</dbReference>
<dbReference type="PDB" id="2RGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=702-1016"/>
</dbReference>
<dbReference type="PDB" id="3B2U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.58"/>
<property type="chains" value="A/B/E/I/M/P/S/V=335-538"/>
</dbReference>
<dbReference type="PDB" id="3B2V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="3BEL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=702-1016"/>
</dbReference>
<dbReference type="PDB" id="3BUO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/C=1063-1075"/>
</dbReference>
<dbReference type="PDB" id="3C09">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/D=336-538"/>
</dbReference>
<dbReference type="PDB" id="3G5V">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=311-326"/>
</dbReference>
<dbReference type="PDB" id="3G5Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.59"/>
<property type="chains" value="E=311-326"/>
</dbReference>
<dbReference type="PDB" id="3GOP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=669-1022"/>
</dbReference>
<dbReference type="PDB" id="3GT8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="A/B/C/D=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3IKA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="3LZB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B/C/D/E/F/G/H=696-983"/>
</dbReference>
<dbReference type="PDB" id="3NJP">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=25-638"/>
</dbReference>
<dbReference type="PDB" id="3OB2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1063-1074"/>
</dbReference>
<dbReference type="PDB" id="3OP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="C/D=1066-1076"/>
</dbReference>
<dbReference type="PDB" id="3P0Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=334-538"/>
</dbReference>
<dbReference type="PDB" id="3PFV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="C/D=1066-1076"/>
</dbReference>
<dbReference type="PDB" id="3POZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3QWQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=1-642"/>
</dbReference>
<dbReference type="PDB" id="3UG1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3UG2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VJN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.34"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VJO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="3VRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="B=1062-1074"/>
</dbReference>
<dbReference type="PDB" id="3VRR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="C=1062-1074"/>
</dbReference>
<dbReference type="PDB" id="3W2O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=698-1022"/>
</dbReference>
<dbReference type="PDB" id="3W2S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3W32">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="3W33">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4G5J">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4G5P">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.17"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4HJO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4I1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I20">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.34"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I21">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.37"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I22">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.71"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I23">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4I24">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4JQ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JQ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.83"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JR3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4JRV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1021"/>
</dbReference>
<dbReference type="PDB" id="4KRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=335-538"/>
</dbReference>
<dbReference type="PDB" id="4KRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.66"/>
<property type="chains" value="A/C/E/G/I/K=335-538"/>
</dbReference>
<dbReference type="PDB" id="4KRO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="4KRP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.82"/>
<property type="chains" value="A=25-642"/>
</dbReference>
<dbReference type="PDB" id="4LI5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.64"/>
<property type="chains" value="A=696-1020"/>
</dbReference>
<dbReference type="PDB" id="4LL0">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.00"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4LQM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4LRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.53"/>
<property type="chains" value="A/B/C/D/E=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4R3P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=696-1018"/>
</dbReference>
<dbReference type="PDB" id="4R3R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A=696-1018"/>
</dbReference>
<dbReference type="PDB" id="4R5S">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIX">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.98"/>
<property type="chains" value="B/D=682-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4RJ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4TKS">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4UIP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=26-637"/>
</dbReference>
<dbReference type="PDB" id="4UV7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=25-645"/>
</dbReference>
<dbReference type="PDB" id="4WD5">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A/B=694-1022"/>
</dbReference>
<dbReference type="PDB" id="4WKQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4WRG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZAU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZJV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="4ZSE">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.97"/>
<property type="chains" value="A/B/C/D=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8K">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5C8N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAO">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CAV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.73"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5CNN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B=696-1042"/>
</dbReference>
<dbReference type="PDB" id="5CNO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="A/B/X=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5CZH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="5CZI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=694-1022"/>
</dbReference>
<dbReference type="PDB" id="5D41">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A/B=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EDR">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.78"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5EM8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5FED">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5FEE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5FEQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GMP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GNK">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=696-988"/>
</dbReference>
<dbReference type="PDB" id="5GTY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.14"/>
<property type="chains" value="A/B/C/D/E/F/G/H=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5GTZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.46"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HCZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.52"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HIB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.85"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5HIC">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5J9Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=697-1019"/>
</dbReference>
<dbReference type="PDB" id="5J9Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=696-1020"/>
</dbReference>
<dbReference type="PDB" id="5JEB">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5LV6">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=634-677"/>
</dbReference>
<dbReference type="PDB" id="5SX4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="M/N=335-525"/>
</dbReference>
<dbReference type="PDB" id="5SX5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="M/N=335-525"/>
</dbReference>
<dbReference type="PDB" id="5U8L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.46"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UG9">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.33"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGA">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.82"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.53"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UGC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.58"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5UWD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.06"/>
<property type="chains" value="A=695-1022"/>
</dbReference>
<dbReference type="PDB" id="5WB7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.94"/>
<property type="chains" value="A/B/C/D=25-525"/>
</dbReference>
<dbReference type="PDB" id="5WB8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/D=25-525"/>
</dbReference>
<dbReference type="PDB" id="5XGM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="A=696-1022"/>
</dbReference>
<dbReference type="PDB" id="5XGN">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=696-1022"/>
</dbReference>
<dbReference type="PDB" id="6B3S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/E/I=335-538"/>
</dbReference>
<dbReference type="PDBsum" id="1DNQ"/>
<dbReference type="PDBsum" id="1DNR"/>
<dbReference type="PDBsum" id="1IVO"/>
<dbReference type="PDBsum" id="1M14"/>
<dbReference type="PDBsum" id="1M17"/>
<dbReference type="PDBsum" id="1MOX"/>
<dbReference type="PDBsum" id="1NQL"/>
<dbReference type="PDBsum" id="1XKK"/>
<dbReference type="PDBsum" id="1YY9"/>
<dbReference type="PDBsum" id="1Z9I"/>
<dbReference type="PDBsum" id="2EB2"/>
<dbReference type="PDBsum" id="2EB3"/>
<dbReference type="PDBsum" id="2EXP"/>
<dbReference type="PDBsum" id="2EXQ"/>
<dbReference type="PDBsum" id="2GS2"/>
<dbReference type="PDBsum" id="2GS6"/>
<dbReference type="PDBsum" id="2GS7"/>
<dbReference type="PDBsum" id="2ITN"/>
<dbReference type="PDBsum" id="2ITO"/>
<dbReference type="PDBsum" id="2ITP"/>
<dbReference type="PDBsum" id="2ITQ"/>
<dbReference type="PDBsum" id="2ITT"/>
<dbReference type="PDBsum" id="2ITU"/>
<dbReference type="PDBsum" id="2ITV"/>
<dbReference type="PDBsum" id="2ITW"/>
<dbReference type="PDBsum" id="2ITX"/>
<dbReference type="PDBsum" id="2ITY"/>
<dbReference type="PDBsum" id="2ITZ"/>
<dbReference type="PDBsum" id="2J5E"/>
<dbReference type="PDBsum" id="2J5F"/>
<dbReference type="PDBsum" id="2J6M"/>
<dbReference type="PDBsum" id="2JIT"/>
<dbReference type="PDBsum" id="2JIU"/>
<dbReference type="PDBsum" id="2JIV"/>
<dbReference type="PDBsum" id="2KS1"/>
<dbReference type="PDBsum" id="2M0B"/>
<dbReference type="PDBsum" id="2M20"/>
<dbReference type="PDBsum" id="2N5S"/>
<dbReference type="PDBsum" id="2RF9"/>
<dbReference type="PDBsum" id="2RFD"/>
<dbReference type="PDBsum" id="2RFE"/>
<dbReference type="PDBsum" id="2RGP"/>
<dbReference type="PDBsum" id="3B2U"/>
<dbReference type="PDBsum" id="3B2V"/>
<dbReference type="PDBsum" id="3BEL"/>
<dbReference type="PDBsum" id="3BUO"/>
<dbReference type="PDBsum" id="3C09"/>
<dbReference type="PDBsum" id="3G5V"/>
<dbReference type="PDBsum" id="3G5Y"/>
<dbReference type="PDBsum" id="3GOP"/>
<dbReference type="PDBsum" id="3GT8"/>
<dbReference type="PDBsum" id="3IKA"/>
<dbReference type="PDBsum" id="3LZB"/>
<dbReference type="PDBsum" id="3NJP"/>
<dbReference type="PDBsum" id="3OB2"/>
<dbReference type="PDBsum" id="3OP0"/>
<dbReference type="PDBsum" id="3P0Y"/>
<dbReference type="PDBsum" id="3PFV"/>
<dbReference type="PDBsum" id="3POZ"/>
<dbReference type="PDBsum" id="3QWQ"/>
<dbReference type="PDBsum" id="3UG1"/>
<dbReference type="PDBsum" id="3UG2"/>
<dbReference type="PDBsum" id="3VJN"/>
<dbReference type="PDBsum" id="3VJO"/>
<dbReference type="PDBsum" id="3VRP"/>
<dbReference type="PDBsum" id="3VRR"/>
<dbReference type="PDBsum" id="3W2O"/>
<dbReference type="PDBsum" id="3W2P"/>
<dbReference type="PDBsum" id="3W2Q"/>
<dbReference type="PDBsum" id="3W2R"/>
<dbReference type="PDBsum" id="3W2S"/>
<dbReference type="PDBsum" id="3W32"/>
<dbReference type="PDBsum" id="3W33"/>
<dbReference type="PDBsum" id="4G5J"/>
<dbReference type="PDBsum" id="4G5P"/>
<dbReference type="PDBsum" id="4HJO"/>
<dbReference type="PDBsum" id="4I1Z"/>
<dbReference type="PDBsum" id="4I20"/>
<dbReference type="PDBsum" id="4I21"/>
<dbReference type="PDBsum" id="4I22"/>
<dbReference type="PDBsum" id="4I23"/>
<dbReference type="PDBsum" id="4I24"/>
<dbReference type="PDBsum" id="4JQ7"/>
<dbReference type="PDBsum" id="4JQ8"/>
<dbReference type="PDBsum" id="4JR3"/>
<dbReference type="PDBsum" id="4JRV"/>
<dbReference type="PDBsum" id="4KRL"/>
<dbReference type="PDBsum" id="4KRM"/>
<dbReference type="PDBsum" id="4KRO"/>
<dbReference type="PDBsum" id="4KRP"/>
<dbReference type="PDBsum" id="4LI5"/>
<dbReference type="PDBsum" id="4LL0"/>
<dbReference type="PDBsum" id="4LQM"/>
<dbReference type="PDBsum" id="4LRM"/>
<dbReference type="PDBsum" id="4R3P"/>
<dbReference type="PDBsum" id="4R3R"/>
<dbReference type="PDBsum" id="4R5S"/>
<dbReference type="PDBsum" id="4RIW"/>
<dbReference type="PDBsum" id="4RIX"/>
<dbReference type="PDBsum" id="4RIY"/>
<dbReference type="PDBsum" id="4RJ4"/>
<dbReference type="PDBsum" id="4RJ5"/>
<dbReference type="PDBsum" id="4RJ6"/>
<dbReference type="PDBsum" id="4RJ7"/>
<dbReference type="PDBsum" id="4RJ8"/>
<dbReference type="PDBsum" id="4TKS"/>
<dbReference type="PDBsum" id="4UIP"/>
<dbReference type="PDBsum" id="4UV7"/>
<dbReference type="PDBsum" id="4WD5"/>
<dbReference type="PDBsum" id="4WKQ"/>
<dbReference type="PDBsum" id="4WRG"/>
<dbReference type="PDBsum" id="4ZAU"/>
<dbReference type="PDBsum" id="4ZJV"/>
<dbReference type="PDBsum" id="4ZSE"/>
<dbReference type="PDBsum" id="5C8K"/>
<dbReference type="PDBsum" id="5C8M"/>
<dbReference type="PDBsum" id="5C8N"/>
<dbReference type="PDBsum" id="5CAL"/>
<dbReference type="PDBsum" id="5CAN"/>
<dbReference type="PDBsum" id="5CAO"/>
<dbReference type="PDBsum" id="5CAP"/>
<dbReference type="PDBsum" id="5CAQ"/>
<dbReference type="PDBsum" id="5CAS"/>
<dbReference type="PDBsum" id="5CAU"/>
<dbReference type="PDBsum" id="5CAV"/>
<dbReference type="PDBsum" id="5CNN"/>
<dbReference type="PDBsum" id="5CNO"/>
<dbReference type="PDBsum" id="5CZH"/>
<dbReference type="PDBsum" id="5CZI"/>
<dbReference type="PDBsum" id="5D41"/>
<dbReference type="PDBsum" id="5EDP"/>
<dbReference type="PDBsum" id="5EDQ"/>
<dbReference type="PDBsum" id="5EDR"/>
<dbReference type="PDBsum" id="5EM5"/>
<dbReference type="PDBsum" id="5EM6"/>
<dbReference type="PDBsum" id="5EM7"/>
<dbReference type="PDBsum" id="5EM8"/>
<dbReference type="PDBsum" id="5FED"/>
<dbReference type="PDBsum" id="5FEE"/>
<dbReference type="PDBsum" id="5FEQ"/>
<dbReference type="PDBsum" id="5GMP"/>
<dbReference type="PDBsum" id="5GNK"/>
<dbReference type="PDBsum" id="5GTY"/>
<dbReference type="PDBsum" id="5GTZ"/>
<dbReference type="PDBsum" id="5HCX"/>
<dbReference type="PDBsum" id="5HCY"/>
<dbReference type="PDBsum" id="5HCZ"/>
<dbReference type="PDBsum" id="5HG5"/>
<dbReference type="PDBsum" id="5HG7"/>
<dbReference type="PDBsum" id="5HG8"/>
<dbReference type="PDBsum" id="5HG9"/>
<dbReference type="PDBsum" id="5HIB"/>
<dbReference type="PDBsum" id="5HIC"/>
<dbReference type="PDBsum" id="5J9Y"/>
<dbReference type="PDBsum" id="5J9Z"/>
<dbReference type="PDBsum" id="5JEB"/>
<dbReference type="PDBsum" id="5LV6"/>
<dbReference type="PDBsum" id="5SX4"/>
<dbReference type="PDBsum" id="5SX5"/>
<dbReference type="PDBsum" id="5U8L"/>
<dbReference type="PDBsum" id="5UG8"/>
<dbReference type="PDBsum" id="5UG9"/>
<dbReference type="PDBsum" id="5UGA"/>
<dbReference type="PDBsum" id="5UGB"/>
<dbReference type="PDBsum" id="5UGC"/>
<dbReference type="PDBsum" id="5UWD"/>
<dbReference type="PDBsum" id="5WB7"/>
<dbReference type="PDBsum" id="5WB8"/>
<dbReference type="PDBsum" id="5XGM"/>
<dbReference type="PDBsum" id="5XGN"/>
<dbReference type="PDBsum" id="6B3S"/>
<dbReference type="DisProt" id="DP00309"/>
<dbReference type="ProteinModelPortal" id="P00533"/>
<dbReference type="SMR" id="P00533"/>
<dbReference type="BioGrid" id="108276">
<property type="interactions" value="1200"/>
</dbReference>
<dbReference type="CORUM" id="P00533"/>
<dbReference type="DIP" id="DIP-405N"/>
<dbReference type="ELM" id="P00533"/>
<dbReference type="IntAct" id="P00533">
<property type="interactions" value="494"/>
</dbReference>
<dbReference type="MINT" id="MINT-206389"/>
<dbReference type="STRING" id="9606.ENSP00000275493"/>
<dbReference type="BindingDB" id="P00533"/>
<dbReference type="ChEMBL" id="CHEMBL203"/>
<dbReference type="DrugBank" id="DB08916">
<property type="generic name" value="Afatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00002">
<property type="generic name" value="Cetuximab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05424">
<property type="generic name" value="CI-1033"/>
</dbReference>
<dbReference type="DrugBank" id="DB00530">
<property type="generic name" value="Erlotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB03496">
<property type="generic name" value="Flavopiridol"/>
</dbReference>
<dbReference type="DrugBank" id="DB00317">
<property type="generic name" value="Gefitinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB05324">
<property type="generic name" value="HuMax-EGFr"/>
</dbReference>
<dbReference type="DrugBank" id="DB11737">
<property type="generic name" value="Icotinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB04988">
<property type="generic name" value="IGN311"/>
</dbReference>
<dbReference type="DrugBank" id="DB05774">
<property type="generic name" value="IMC-11F8"/>
</dbReference>
<dbReference type="DrugBank" id="DB05900">
<property type="generic name" value="INSM-18"/>
</dbReference>
<dbReference type="DrugBank" id="DB01259">
<property type="generic name" value="Lapatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00281">
<property type="generic name" value="Lidocaine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05101">
<property type="generic name" value="Matuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB07662">
<property type="generic name" value="N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE"/>
</dbReference>
<dbReference type="DrugBank" id="DB09559">
<property type="generic name" value="Necitumumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB13164">
<property type="generic name" value="Olmutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB09330">
<property type="generic name" value="Osimertinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01269">
<property type="generic name" value="Panitumumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05374">
<property type="generic name" value="Rindopepimut"/>
</dbReference>
<dbReference type="DrugBank" id="DB07602">
<property type="generic name" value="S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05294">
<property type="generic name" value="Vandetanib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1797"/>
<dbReference type="iPTMnet" id="P00533"/>
<dbReference type="PhosphoSitePlus" id="P00533"/>
<dbReference type="SwissPalm" id="P00533"/>
<dbReference type="UniCarbKB" id="P00533"/>
<dbReference type="BioMuta" id="EGFR"/>
<dbReference type="DMDM" id="2811086"/>
<dbReference type="SWISS-2DPAGE" id="P00533"/>
<dbReference type="EPD" id="P00533"/>
<dbReference type="MaxQB" id="P00533"/>
<dbReference type="PaxDb" id="P00533"/>
<dbReference type="PeptideAtlas" id="P00533"/>
<dbReference type="PRIDE" id="P00533"/>
<dbReference type="DNASU" id="1956"/>
<dbReference type="Ensembl" id="ENST00000275493">
<molecule id="P00533-1"/>
<property type="protein sequence ID" value="ENSP00000275493"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000342916">
<molecule id="P00533-4"/>
<property type="protein sequence ID" value="ENSP00000342376"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000344576">
<molecule id="P00533-3"/>
<property type="protein sequence ID" value="ENSP00000345973"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000420316">
<molecule id="P00533-2"/>
<property type="protein sequence ID" value="ENSP00000413843"/>
<property type="gene ID" value="ENSG00000146648"/>
</dbReference>
<dbReference type="GeneID" id="1956"/>
<dbReference type="KEGG" id="hsa:1956"/>
<dbReference type="UCSC" id="uc003tqh.4">
<molecule id="P00533-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1956"/>
<dbReference type="DisGeNET" id="1956"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000146648.15"/>
<dbReference type="GeneCards" id="EGFR"/>
<dbReference type="HGNC" id="HGNC:3236">
<property type="gene designation" value="EGFR"/>
</dbReference>
<dbReference type="HPA" id="CAB000035"/>
<dbReference type="HPA" id="CAB068186"/>
<dbReference type="HPA" id="CAB073534"/>
<dbReference type="HPA" id="HPA001200"/>
<dbReference type="HPA" id="HPA018530"/>
<dbReference type="MalaCards" id="EGFR"/>
<dbReference type="MIM" id="131550">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="211980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="616069">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P00533"/>
<dbReference type="OpenTargets" id="ENSG00000146648"/>
<dbReference type="Orphanet" id="251579">
<property type="disease" value="Giant cell glioblastoma"/>
</dbReference>
<dbReference type="Orphanet" id="251576">
<property type="disease" value="Gliosarcoma"/>
</dbReference>
<dbReference type="Orphanet" id="294023">
<property type="disease" value="Neonatal inflammatory skin and bowel disease"/>
</dbReference>
<dbReference type="Orphanet" id="357191">
<property type="disease" value="Selection of therapeutic option in non-small cell lung carcinoma"/>
</dbReference>
<dbReference type="PharmGKB" id="PA7360"/>
<dbReference type="eggNOG" id="KOG1025">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNSR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOVERGEN" id="HBG000490"/>
<dbReference type="InParanoid" id="P00533"/>
<dbReference type="KO" id="K04361"/>
<dbReference type="OMA" id="VCRKCHP"/>
<dbReference type="OrthoDB" id="EOG091G00NO"/>
<dbReference type="PhylomeDB" id="P00533"/>
<dbReference type="TreeFam" id="TF106002"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1227986">
<property type="pathway name" value="Signaling by ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236382">
<property type="pathway name" value="Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1236394">
<property type="pathway name" value="Signaling by ERBB4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1251932">
<property type="pathway name" value="PLCG1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-177929">
<property type="pathway name" value="Signaling by EGFR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-179812">
<property type="pathway name" value="GRB2 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180292">
<property type="pathway name" value="GAB1 signalosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180336">
<property type="pathway name" value="SHC1 events in EGFR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-182971">
<property type="pathway name" value="EGFR downregulation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963640">
<property type="pathway name" value="GRB2 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-212718">
<property type="pathway name" value="EGFR interacts with phospholipase C-gamma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2179392">
<property type="pathway name" value="EGFR Transactivation by Gastrin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5637810">
<property type="pathway name" value="Constitutive Signaling by EGFRvIII"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5638303">
<property type="pathway name" value="Inhibition of Signaling by Overexpressed EGFR"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785631">
<property type="pathway name" value="ERBB2 Regulates Cell Motility"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856825">
<property type="pathway name" value="Cargo recognition for clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8857538">
<property type="pathway name" value="PTK6 promotes HIF1A stabilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8863795">
<property type="pathway name" value="Downregulation of ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="SignaLink" id="P00533"/>
<dbReference type="SIGNOR" id="P00533"/>
<dbReference type="ChiTaRS" id="EGFR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P00533"/>
<dbReference type="GeneWiki" id="Epidermal_growth_factor_receptor"/>
<dbReference type="GenomeRNAi" id="1956"/>
<dbReference type="PMAP-CutDB" id="P00533"/>
<dbReference type="PRO" id="PR:P00533"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 7"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000146648"/>
<dbReference type="ExpressionAtlas" id="P00533">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P00533">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030665">
<property type="term" value="C:clathrin-coated vesicle membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031901">
<property type="term" value="C:early endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030139">
<property type="term" value="C:endocytic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005789">
<property type="term" value="C:endoplasmic reticulum membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000139">
<property type="term" value="C:Golgi membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097489">
<property type="term" value="C:multivesicular body, internal vesicle lumen"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031965">
<property type="term" value="C:nuclear membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0070435">
<property type="term" value="C:Shc-EGFR complex"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045202">
<property type="term" value="C:synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051015">
<property type="term" value="F:actin filament binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048408">
<property type="term" value="F:epidermal growth factor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005006">
<property type="term" value="F:epidermal growth factor-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0005178">
<property type="term" value="F:integrin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004709">
<property type="term" value="F:MAP kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004716">
<property type="term" value="F:signal transducer, downstream of receptor, with protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001618">
<property type="term" value="F:virus receptor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043006">
<property type="term" value="P:activation of phospholipase A2 activity by calcium-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007202">
<property type="term" value="P:activation of phospholipase C activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048143">
<property type="term" value="P:astrocyte activation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0098609">
<property type="term" value="P:cell-cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071230">
<property type="term" value="P:cellular response to amino acid stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071276">
<property type="term" value="P:cellular response to cadmium ion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0071549">
<property type="term" value="P:cellular response to dexamethasone stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071392">
<property type="term" value="P:cellular response to estradiol stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0034614">
<property type="term" value="P:cellular response to reactive oxygen species"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0021795">
<property type="term" value="P:cerebral cortex cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048546">
<property type="term" value="P:digestive tract morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016101">
<property type="term" value="P:diterpenoid metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001892">
<property type="term" value="P:embryonic placenta development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061029">
<property type="term" value="P:eyelid development in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001942">
<property type="term" value="P:hair follicle development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042743">
<property type="term" value="P:hydrogen peroxide metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097421">
<property type="term" value="P:liver regeneration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030324">
<property type="term" value="P:lung development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010960">
<property type="term" value="P:magnesium ion homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007494">
<property type="term" value="P:midgut development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060571">
<property type="term" value="P:morphogenesis of an epithelial fold"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905208">
<property type="term" value="P:negative regulation of cardiocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042059">
<property type="term" value="P:negative regulation of epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:1901185">
<property type="term" value="P:negative regulation of ERBB signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045930">
<property type="term" value="P:negative regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042177">
<property type="term" value="P:negative regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048812">
<property type="term" value="P:neuron projection morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001503">
<property type="term" value="P:ossification"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042698">
<property type="term" value="P:ovulation cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038083">
<property type="term" value="P:peptidyl-tyrosine autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018108">
<property type="term" value="P:peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097755">
<property type="term" value="P:positive regulation of blood vessel diameter"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045780">
<property type="term" value="P:positive regulation of bone resorption"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035413">
<property type="term" value="P:positive regulation of catenin import into nucleus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0031659">
<property type="term" value="P:positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045739">
<property type="term" value="P:positive regulation of DNA repair"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045740">
<property type="term" value="P:positive regulation of DNA replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048146">
<property type="term" value="P:positive regulation of fibroblast proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050729">
<property type="term" value="P:positive regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045429">
<property type="term" value="P:positive regulation of nitric oxide biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033138">
<property type="term" value="P:positive regulation of peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042327">
<property type="term" value="P:positive regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903800">
<property type="term" value="P:positive regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902722">
<property type="term" value="P:positive regulation of prolactin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1900020">
<property type="term" value="P:positive regulation of protein kinase C activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903078">
<property type="term" value="P:positive regulation of protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ParkinsonsUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048661">
<property type="term" value="P:positive regulation of smooth muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032930">
<property type="term" value="P:positive regulation of superoxide anion generation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051968">
<property type="term" value="P:positive regulation of synaptic transmission, glutamatergic"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0045907">
<property type="term" value="P:positive regulation of vasoconstriction"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051205">
<property type="term" value="P:protein insertion into membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0046328">
<property type="term" value="P:regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0050999">
<property type="term" value="P:regulation of nitric-oxide synthase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050730">
<property type="term" value="P:regulation of peptidyl-tyrosine phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051592">
<property type="term" value="P:response to calcium ion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033590">
<property type="term" value="P:response to cobalamin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033594">
<property type="term" value="P:response to hydroxyisoflavone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006970">
<property type="term" value="P:response to osmotic stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006950">
<property type="term" value="P:response to stress"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070141">
<property type="term" value="P:response to UV-A"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007435">
<property type="term" value="P:salivary gland morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043586">
<property type="term" value="P:tongue development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006412">
<property type="term" value="P:translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.5.100">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.20.20">
<property type="match status" value="4"/>
</dbReference>
<dbReference type="InterPro" id="IPR021157">
<property type="entry name" value="Cyt_c1_TM_anchor_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR006211">
<property type="entry name" value="Furin-like_Cys-rich_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006212">
<property type="entry name" value="Furin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR032778">
<property type="entry name" value="GF_recep_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_cys_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="LRR_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000494">
<property type="entry name" value="Rcpt_L-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036941">
<property type="entry name" value="Rcpt_L-dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016245">
<property type="entry name" value="Tyr_kinase_EGF/ERB/XmrK_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00757">
<property type="entry name" value="Furin-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14843">
<property type="entry name" value="GF_recep_IV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01030">
<property type="entry name" value="Recep_L_domain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000619">
<property type="entry name" value="TyrPK_EGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00261">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52058">
<property type="entry name" value="SSF52058"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0217">Developmental protein</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0256">Endoplasmic reticulum</keyword>
<keyword id="KW-0967">Endosome</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0333">Golgi apparatus</keyword>
<keyword id="KW-1183">Host cell receptor for virus entry</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="51 99">
<location>
<begin position="1"/>
<end position="24"/>
</location>
</feature>
<feature type="chain" description="Epidermal growth factor receptor" id="PRO_0000016665">
<location>
<begin position="25"/>
<end position="1210"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="35">
<location>
<begin position="25"/>
<end position="645"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="35">
<location>
<begin position="646"/>
<end position="668"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="35">
<location>
<begin position="669"/>
<end position="1210"/>
</location>
</feature>
<feature type="repeat" description="Approximate">
<location>
<begin position="75"/>
<end position="300"/>
</location>
</feature>
<feature type="repeat" description="Approximate">
<location>
<begin position="390"/>
<end position="600"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="36">
<location>
<begin position="712"/>
<end position="979"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="718"/>
<end position="726"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP">
<location>
<begin position="790"/>
<end position="791"/>
</location>
</feature>
<feature type="region of interest" description="Important for dimerization, phosphorylation and activation">
<location>
<begin position="688"/>
<end position="704"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="36 37">
<location>
<position position="837"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="745"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="855"/>
</location>
</feature>
<feature type="site" description="Important for interaction with PIK3C2B">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="82">
<location>
<position position="229"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKC and PKD/PRKD1" evidence="40">
<location>
<position position="678"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PKD/PRKD1" evidence="30 31 32 33 40 56 94">
<location>
<position position="693"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="30 94">
<location>
<position position="695"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29 31 33 56">
<location>
<position position="991"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="995"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="29 74">
<location>
<position position="998"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="74">
<location>
<position position="1016"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="33 56">
<location>
<position position="1026"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="1039"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="29">
<location>
<position position="1041"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="1042"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29 30 31 32">
<location>
<position position="1064"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="109">
<location>
<position position="1069"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="94">
<location>
<position position="1070"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="94">
<location>
<position position="1071"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="30">
<location>
<position position="1081"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="48">
<location>
<position position="1092"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="48 92">
<location>
<position position="1110"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29 30 33">
<location>
<position position="1166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="28">
<location>
<position position="1172"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="28 30 31 74 76">
<location>
<position position="1197"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="81">
<location>
<position position="1199"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine; atypical; partial" id="CAR_000227" evidence="41 45 47 56 80">
<location>
<position position="56"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; atypical" evidence="80">
<location>
<position position="73"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="47 56 97">
<location>
<position position="128"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="45 47 56 80 97">
<location>
<position position="175"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="45 47 56 80">
<location>
<position position="196"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="41 45 46 47 56 70 80">
<location>
<position position="352"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="41 45 46 47 56 80">
<location>
<position position="361"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="47 56 70 97">
<location>
<position position="413"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="45 46 47 56 80 97">
<location>
<position position="444"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="46 47 56 80 97">
<location>
<position position="528"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; partial" evidence="41 46 47 56 70">
<location>
<position position="568"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine; partial" evidence="41 46 47 56">
<location>
<position position="603"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (high mannose) asparagine" evidence="108">
<location>
<position position="623"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="31"/>
<end position="58"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="157"/>
<end position="187"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="190"/>
<end position="199"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="194"/>
<end position="207"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="215"/>
<end position="223"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="219"/>
<end position="231"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="232"/>
<end position="240"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="236"/>
<end position="248"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="264"/>
<end position="291"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="295"/>
<end position="307"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="311"/>
<end position="326"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="329"/>
<end position="333"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="337"/>
<end position="362"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="470"/>
<end position="499"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="506"/>
<end position="515"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="510"/>
<end position="523"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="526"/>
<end position="535"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="539"/>
<end position="555"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="558"/>
<end position="571"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="562"/>
<end position="579"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="582"/>
<end position="591"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="595"/>
<end position="617"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="620"/>
<end position="628"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="624"/>
<end position="636"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="60">
<location>
<position position="716"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="60">
<location>
<position position="737"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="60">
<location>
<position position="754"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="60">
<location>
<position position="867"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="60">
<location>
<position position="929"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="60">
<location>
<position position="970"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002887" evidence="103 104 105 106">
<original>FL</original>
<variation>LS</variation>
<location>
<begin position="404"/>
<end position="405"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002888" evidence="103 104 105 106">
<location>
<begin position="406"/>
<end position="1210"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002889" evidence="102">
<original>CTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLR</original>
<variation>PGNESLKAMLFCLFKLSSCNQSNDGSVSHQSGSPAAQESCLGWIPSLLPSEFQLGWGGCSHLHAWPSASVIITASSCH</variation>
<location>
<begin position="628"/>
<end position="705"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002891" evidence="102">
<original>C</original>
<variation>S</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_002892" evidence="102">
<location>
<begin position="629"/>
<end position="1210"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002890" evidence="102">
<location>
<begin position="706"/>
<end position="1210"/>
</location>
</feature>
<feature type="sequence variant" description="Variant EGFR vIII; found in a lung cancer sample; somatic mutation; induces lung cancer when exogenously expressed." id="VAR_066493" evidence="61">
<location>
<begin position="30"/>
<end position="297"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17289589." id="VAR_019293" evidence="100">
<original>R</original>
<variation>Q</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17336639." id="VAR_019294" evidence="100">
<original>P</original>
<variation>R</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In NISBD2; loss of function; the mutant does not localize to the cell membrane; has diffuse cytoplasmic localization; dbSNP:rs606231253." id="VAR_072435" evidence="90">
<original>G</original>
<variation>D</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2227983." id="VAR_019295" evidence="64 100">
<original>R</original>
<variation>K</variation>
<location>
<position position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17337079." id="VAR_019296" evidence="100">
<original>V</original>
<variation>I</variation>
<location>
<position position="674"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517085." id="VAR_026084" evidence="54 58 59">
<original>E</original>
<variation>A</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs397517085." id="VAR_069498" evidence="54 58">
<original>E</original>
<variation>G</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs727504256." id="VAR_026085" evidence="59">
<original>E</original>
<variation>K</variation>
<location>
<position position="709"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913428." id="VAR_026086" evidence="59">
<original>G</original>
<variation>A</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs28929495." id="VAR_026087" evidence="54 59">
<original>G</original>
<variation>C</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913428." id="VAR_026088" evidence="59">
<original>G</original>
<variation>D</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; somatic mutation; strongly increased kinase activity; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs28929495." id="VAR_019297" evidence="49 54 58 59 65">
<original>G</original>
<variation>S</variation>
<location>
<position position="719"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs1051753269." id="VAR_026089" evidence="59">
<original>G</original>
<variation>S</variation>
<location>
<position position="724"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913420." id="VAR_026090" evidence="59">
<original>E</original>
<variation>K</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069499" evidence="54">
<original>ELREATS</original>
<variation>D</variation>
<location>
<begin position="746"/>
<end position="752"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069500" evidence="54">
<original>ELREAT</original>
<variation>A</variation>
<location>
<begin position="746"/>
<end position="751"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026092" evidence="54">
<location>
<begin position="746"/>
<end position="750"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026091" evidence="59">
<location>
<position position="746"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_069501" evidence="54">
<location>
<begin position="747"/>
<end position="751"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026094" evidence="59">
<location>
<begin position="747"/>
<end position="749"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026093" evidence="59">
<original>L</original>
<variation>F</variation>
<location>
<position position="747"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026095" evidence="59">
<original>R</original>
<variation>P</variation>
<location>
<position position="748"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026096" evidence="59">
<location>
<begin position="752"/>
<end position="759"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913465." id="VAR_069502" evidence="54 58">
<original>S</original>
<variation>I</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs147149347." id="VAR_069503" evidence="54">
<original>V</original>
<variation>M</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026097" evidence="59">
<original>Q</original>
<variation>R</variation>
<location>
<position position="787"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; increased kinase activity; dbSNP:rs121434569." id="VAR_026098" evidence="59 68">
<original>T</original>
<variation>M</variation>
<location>
<position position="790"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517126." id="VAR_026099" evidence="54 58 59">
<original>L</original>
<variation>V</variation>
<location>
<position position="833"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs397517127." id="VAR_026100" evidence="59">
<original>V</original>
<variation>L</variation>
<location>
<position position="834"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs397517128." id="VAR_069504" evidence="54 58">
<original>H</original>
<variation>L</variation>
<location>
<position position="835"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; more sensitive to gefitinib than wild-type; dbSNP:rs864621996." id="VAR_069505" evidence="54 58">
<original>L</original>
<variation>V</variation>
<location>
<position position="838"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; dbSNP:rs121913443." id="VAR_026101" evidence="59">
<original>L</original>
<variation>M</variation>
<location>
<position position="858"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity; more sensitive to gefitinib than wild-type; dbSNP:rs121434568." id="VAR_019298" evidence="49 54 58 59 65">
<original>L</original>
<variation>R</variation>
<location>
<position position="858"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913444." id="VAR_026102" evidence="54 58 59">
<original>L</original>
<variation>Q</variation>
<location>
<position position="861"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a lung cancer sample." id="VAR_026103" evidence="59">
<original>G</original>
<variation>E</variation>
<location>
<position position="873"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17337451." id="VAR_019299" evidence="100">
<original>R</original>
<variation>G</variation>
<location>
<position position="962"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17290699." id="VAR_019300" evidence="100">
<original>H</original>
<variation>P</variation>
<location>
<position position="988"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34352568." id="VAR_042095" evidence="64">
<original>L</original>
<variation>R</variation>
<location>
<position position="1034"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35918369." id="VAR_042096" evidence="64">
<original>A</original>
<variation>V</variation>
<location>
<position position="1210"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309." evidence="45">
<original>Y</original>
<variation>A</variation>
<location>
<position position="275"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-309." evidence="45">
<original>F</original>
<variation>A</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-275. Strongly reduced autophosphorylation and activation of downstream kinases; when associated with A-287." evidence="45">
<original>R</original>
<variation>S</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes autophosphorylation and activation of downstream kinases." evidence="45">
<original>R</original>
<variation>E</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases intramolecular interactions and facilitates EGF binding." evidence="46">
<original>DGPH</original>
<variation>AGPA</variation>
<location>
<begin position="587"/>
<end position="590"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases intramolecular interactions and facilitates EGF binding." evidence="46">
<original>K</original>
<variation>A</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="73 74">
<original>L</original>
<variation>A</variation>
<location>
<position position="688"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced autophosphorylation." evidence="73">
<original>V</original>
<variation>A</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase." evidence="73">
<original>V</original>
<variation>M</variation>
<location>
<position position="689"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="73 74">
<original>E</original>
<variation>A</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="73 74">
<original>L</original>
<variation>A</variation>
<variation>P</variation>
<location>
<position position="692"/>
</location>
</feature>
<feature type="mutagenesis site" description="Increased phosphorylation." evidence="73">
<original>T</original>
<variation>A</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="73">
<original>T</original>
<variation>D</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation." evidence="73">
<original>P</original>
<variation>A</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="73">
<original>P</original>
<variation>A</variation>
<location>
<position position="699"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="73">
<original>N</original>
<variation>A</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="73">
<original>L</original>
<variation>A</variation>
<location>
<position position="704"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="73">
<original>R</original>
<variation>A</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation." evidence="73">
<original>I</original>
<variation>A</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="73">
<original>K</original>
<variation>A</variation>
<variation>M</variation>
<location>
<position position="745"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduced phosphorylation.">
<original>D</original>
<variation>A</variation>
<location>
<position position="974"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation." evidence="74">
<original>R</original>
<variation>A</variation>
<location>
<position position="977"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutively activated kinase." evidence="74">
<original>ED</original>
<variation>RK</variation>
<location>
<begin position="1005"/>
<end position="1006"/>
</location>
</feature>
<feature type="mutagenesis site" description="50% decrease in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1197. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1092." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1016"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on interaction with CBLC." evidence="87">
<original>Q</original>
<variation>G</variation>
<location>
<position position="1067"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly decreases interaction with CBLC." evidence="87">
<original>R</original>
<variation>G</variation>
<location>
<position position="1068"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CBLC." evidence="87">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1069"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B. Abolishes interaction with PIK3C2B; when associated with F-1197 and F-1016." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1092"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1110"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1172"/>
</location>
</feature>
<feature type="mutagenesis site" description="No change in interaction with PIK3C2B. 65% decrease in interaction with PIK3C2B; when associated with F-1016. Abolishes interaction with PIK3C2B; when associated with F-1092 and F-1016." evidence="42">
<original>Y</original>
<variation>F</variation>
<location>
<position position="1197"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA25240." ref="1" evidence="107">
<original>N</original>
<variation>K</variation>
<location>
<position position="540"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="40"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="44"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="60"/>
<end position="69"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="77"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="84"/>
<end position="87"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="89"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="101"/>
<end position="103"/>
</location>
</feature>
<feature type="turn" evidence="21">
<location>
<begin position="114"/>
<end position="116"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="117"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="125"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="145"/>
<end position="152"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="170"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="199"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="211"/>
<end position="214"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="223"/>
<end position="227"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="240"/>
<end position="244"/>
</location>
</feature>
<feature type="turn" evidence="21">
<location>
<begin position="245"/>
<end position="247"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="248"/>
<end position="256"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="259"/>
<end position="263"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="267"/>
<end position="271"/>
</location>
</feature>
<feature type="turn" evidence="21">
<location>
<begin position="272"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="276"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="285"/>
<end position="287"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="290"/>
<end position="294"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="296"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="27">
<location>
<begin position="299"/>
<end position="301"/>
</location>
</feature>
<feature type="strand" evidence="20">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="306"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="313"/>
<end position="315"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="318"/>
<end position="320"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="336"/>
<end position="338"/>
</location>
</feature>
<feature type="turn" evidence="14">
<location>
<begin position="340"/>
<end position="342"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="343"/>
<end position="345"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="353"/>
<end position="355"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="356"/>
<end position="359"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="363"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="369"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="373"/>
<end position="377"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="380"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="389"/>
<end position="397"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="400"/>
<end position="403"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="405"/>
<end position="407"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="418"/>
<end position="420"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="433"/>
<end position="435"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="436"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="458"/>
<end position="464"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="472"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="477"/>
<end position="480"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="481"/>
<end position="483"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="488"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="496"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="25">
<location>
<begin position="508"/>
<end position="510"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="515"/>
<end position="519"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="520"/>
<end position="522"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="523"/>
<end position="526"/>
</location>
</feature>
<feature type="strand" evidence="18">
<location>
<begin position="531"/>
<end position="533"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="535"/>
<end position="537"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="540"/>
<end position="546"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="548"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="554"/>
<end position="557"/>
</location>
</feature>
<feature type="strand" evidence="19">
<location>
<begin position="560"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="566"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="570"/>
<end position="575"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="578"/>
<end position="587"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="590"/>
<end position="594"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="597"/>
<end position="602"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="606"/>
<end position="611"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="615"/>
<end position="619"/>
</location>
</feature>
<feature type="strand" evidence="21">
<location>
<begin position="629"/>
<end position="632"/>
</location>
</feature>
<feature type="helix" evidence="21">
<location>
<begin position="633"/>
<end position="635"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="643"/>
<end position="646"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="648"/>
<end position="669"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="671"/>
<end position="673"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="679"/>
<end position="684"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="685"/>
<end position="687"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="688"/>
<end position="692"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="694"/>
<end position="697"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="703"/>
<end position="706"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="709"/>
<end position="711"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="712"/>
<end position="721"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="724"/>
<end position="731"/>
</location>
</feature>
<feature type="turn" evidence="26">
<location>
<begin position="734"/>
<end position="736"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="740"/>
<end position="747"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="748"/>
<end position="750"/>
</location>
</feature>
<feature type="turn" evidence="15">
<location>
<begin position="753"/>
<end position="755"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="756"/>
<end position="767"/>
</location>
</feature>
<feature type="strand" evidence="17">
<location>
<begin position="772"/>
<end position="774"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="777"/>
<end position="791"/>
</location>
</feature>
<feature type="strand" evidence="16">
<location>
<begin position="794"/>
<end position="797"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="798"/>
<end position="804"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="806"/>
<end position="808"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="811"/>
<end position="830"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="840"/>
<end position="842"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="843"/>
<end position="847"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="850"/>
<end position="853"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="858"/>
<end position="862"/>
</location>
</feature>
<feature type="turn" evidence="13">
<location>
<begin position="863"/>
<end position="865"/>
</location>
</feature>
<feature type="strand" evidence="26">
<location>
<begin position="867"/>
<end position="870"/>
</location>
</feature>
<feature type="strand" evidence="22">
<location>
<begin position="873"/>
<end position="876"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="878"/>
<end position="880"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="883"/>
<end position="888"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="893"/>
<end position="908"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="909"/>
<end position="911"/>
</location>
</feature>
<feature type="turn" evidence="26">
<location>
<begin position="914"/>
<end position="917"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="920"/>
<end position="922"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="923"/>
<end position="928"/>
</location>
</feature>
<feature type="strand" evidence="24">
<location>
<begin position="937"/>
<end position="939"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="941"/>
<end position="950"/>
</location>
</feature>
<feature type="strand" evidence="24">
<location>
<begin position="951"/>
<end position="953"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="955"/>
<end position="957"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="961"/>
<end position="972"/>
</location>
</feature>
<feature type="helix" evidence="26">
<location>
<begin position="975"/>
<end position="977"/>
</location>
</feature>
<feature type="helix" evidence="23">
<location>
<begin position="984"/>
<end position="986"/>
</location>
</feature>
<feature type="turn" evidence="23">
<location>
<begin position="992"/>
<end position="998"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="1004"/>
<end position="1010"/>
</location>
</feature>
<feature type="helix" evidence="13">
<location>
<begin position="1013"/>
<end position="1016"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="1068"/>
<end position="1070"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1IVO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MOX"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1YY9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1Z9I"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GS7"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2ITU"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2KS1"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3B2V"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3G5Y"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3GOP"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3P0Y"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PFV"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3POZ"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3QWQ"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3W2S"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4G5P"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4I21"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRL"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRO"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KRP"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4UV7"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5CZI"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HG8"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JEB"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5SX4"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5UG9"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WB7"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q01279"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000255"/>
<evidence key="36" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10026169"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10228163"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10523301"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10731668"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805725"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11116146"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483589"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12297050"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12620237"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12731890"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12873986"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15118125"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15282549"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15340161"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15374980"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15590694"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15623594"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15837620"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16083266"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16140940"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16205628"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16533793"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16543144"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16672372"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17115032"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17182860"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17349580"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17671655"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18046415"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18227510"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18602463"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19159218"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19172738"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19509291"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19560417"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19563760"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19749156"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19836242"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20471394"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20551055"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20674546"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20837704"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21258366"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21487020"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21516087"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21518868"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22179831"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22298428"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22888118"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23418353"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23912460"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24691054"/>
</source>
</evidence>
<evidence key="91" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25311788"/>
</source>
</evidence>
<evidence key="92" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2543678"/>
</source>
</evidence>
<evidence key="93" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28479384"/>
</source>
</evidence>
<evidence key="94" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3138233"/>
</source>
</evidence>
<evidence key="95" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7657591"/>
</source>
</evidence>
<evidence key="96" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8650580"/>
</source>
</evidence>
<evidence key="97" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8962717"/>
</source>
</evidence>
<evidence key="98" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9852145"/>
</source>
</evidence>
<evidence key="99" type="ECO:0000269">
<source ref="16"/>
</evidence>
<evidence key="100" type="ECO:0000269">
<source ref="7"/>
</evidence>
<evidence key="101" type="ECO:0000269">
<source ref="92"/>
</evidence>
<evidence key="102" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11161793"/>
</source>
</evidence>
<evidence key="103" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7654368"/>
</source>
</evidence>
<evidence key="104" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8918811"/>
</source>
</evidence>
<evidence key="105" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9103388"/>
</source>
</evidence>
<evidence key="106" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="107" type="ECO:0000305"/>
<evidence key="108" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12731890"/>
</source>
</evidence>
<evidence key="109" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="22888118"/>
</source>
</evidence>
<sequence length="1210" mass="134277" checksum="D8A2A50B4EFB6ED2" modified="1997-11-01" version="2" precursor="true">
MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEV
VLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALA
VLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDF
QNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGC
TGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYV
VTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFK
NCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAF
ENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKL
FGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCN
LLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVM
GENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVV
ALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGS
GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI
CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA
RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSY
GVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK
FRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQ
QGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTED
SIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLN
TVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRV
APQSSEFIGA
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>